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Summary 
Natural killer (NK) cells are a subpopulation of lymphocytes that are involved in the 
control of different tumors and infections. Unlike T and B cells, NK cells belong to the 
innate part of the immune system. NK cells carry on their surface a multitude of 
activating and inhibitory receptors. The regulation of NK cell activation depends on a 
balance of positive and negative signals initiated by various receptors. Triggering of 
activating receptors leads to Src family kinase mediated Vav1 phosphorylation, 
whereas inhibitory receptors dephosphorylate Vav1 via the phosphatase SHP-1. This 
makes Vav1 the first point where negative signals can intercept the activating 
signaling cascade. In cooperation with computational biologists we established a 
mathematical model describing these early signaling events to gain insight into the 
integration of positive and negative signals on a molecular level. In quantitative 
mathematical models each equation refers to identifiable processes and parameters 
have physical interpretation (such as concentration, binding affinity and reaction 
rate). Therefore we quantified the concentrations of involved molecules. The 
predictions from the model and our experimental data show that engagement of 
activating receptors results in a rapid switch-like increase of Vav1 phosphorylation. 
Similarly, engagement of inhibitory receptors induces a switch-like dephosphorylation 
of Vav1 that is dominant over activating signals. Comparing experimental results to 
predictions derived from a family of simplified models shows that kinase association 
with the NK cell receptors and the enhanced activity of SHP-1 bound to inhibitory 
receptors is essential to simulate such a physiological response. Interestingly, other 
concepts of immune receptor signaling such as phosphatase segregation and kinase 
autophosphorylation were dispensable for our model. The cytotoxic activity of NK 
cells induced by a combination of activating and inhibitory signals correlates with the 
switch-like Vav1 phosphorylation. Our data are consistent with a central role of Vav1 
in the decision making process of NK cells and enable a novel insight into the 
integration of positive and negative signals during lymphocyte activation. 
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Zusammenfassung 
Natürliche Killerzellen (NK Zellen) sind eine Lymphozytenpopulation, die dazu 
beiträgt verschiedenste Krebserkrankungen und Infektionen zu kontrollieren. Anders 
als T und B Zellen gehören NK Zellen zum angeborenen Immunsystem. NK Zellen 
exprimieren auf ihrer Oberfläche eine Vielzahl aktivierender und inhibierender 
Rezeptoren. Die Regulation der Aktivität von NK Zellen beruht auf einem 
Zusammenspiel der Signale die von den verschiedenen Rezeptoren ausgelöst 
werden. Die Stimulation aktivierender Rezeptoren bewirkt die Phosphorylierung von 
Vav1 durch Kinasen der Src Familie, wohingegen Signale der inhibierenden 
Rezeptoren Vav1 durch die Phosphatase SHP-1 dephosphorylieren können. 
Dadurch ist Vav1 der erste Schritt der aktivierenden Signalkaskade, der von 
inhibierenden Signalen beeinflusst werden kann. Um einen Einblick in die 
Signalverarbeitung auf molekularer Ebene zu bekommen, haben wir in einer 
Kooperation mit Bioinformatikern ein mathematisches Modell aufgestellt, das diese 
frühen Signalprozesse beschreiben kann. In quantitativen mathematischen Modellen 
steht jede Gleichung für einen definierten Prozess und jeder Parameter hat eine 
physikalische Bedeutung (wie Konzentration, Bindungsaffinität und 
Reaktionsgeschwindigkeit). Deshalb haben wir die Konzentrationen der beteiligten 
Proteine quantifiziert. Vorhersagen des Modells und unsere experimentellen 
Ergebnisse zeigten, dass zunehmende Stimulation der aktivierenden Rezeptoren 
einen rapiden Anstieg der Vav1 Phosphorylierung verursacht. Wenn gleichzeitig 
inhibierende Rezeptoren stimuliert werden erfolgt eine Hemmung der Vav1 
Phosphorylierung, die über die aktivierenden Signale dominiert. Der Vergleich 
experimenteller Ergebnisse mit den Berechnungen des Modells zeigt, dass zwei 
Konzepte essentiell sind um die physiologische Reaktion der Vav1 Phosphorylierung 
zu erzeugen: die Assoziation der Kinase mit den Rezeptoren und die Verstärkung der 
SHP-1 Aktivität wenn diese an inhibierende Rezeptoren gebunden ist. Andere 
Prinzipien der Signalverarbeitung, wie Segregation von Phosphatasen von der 
Synapse und Kinase Autophosphorylierung, waren in unserem Modell für eine 
physiologische Reaktion entbehrlich. Wenn NK Zellen durch eine Kombination 
aktivierender und inhibierender Signale stimuliert werden zeigt die zytotoxische 
Aktivität das gleiche schalterartige Verhalten wie die Vav1 Phosphorylierung. Unsere 
Ergebnisse sprechen für eine zentrale Rolle von Vav1 bei der Entscheidungsfindung 
der NK Zellen. Durch das mathematische Modell wird ein neuer Einblick in die 
Verarbeitung aktivierender und inhibierender Signale während der Aktivierung von 
Lymphozyten ermöglicht. 
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1. Introduction 
1.1. An introduction to NK cells 
Natural killer (NK) cells are a subset of lymphocytes that were first described in 1975 
as having the ability to lyse allogenic tumor cells in mice without prior sensitization 
(Herberman et al, 1975a; Herberman et al, 1975b; Kiessling et al, 1975a; Kiessling et 
al, 1975b). This defined the term ‘natural cytotoxicity’ but later on it became clear that 
this is not the only function of NK cells. Additionally, these cells can secrete 
proinflammatory cytokines, play an important role in the defense against various 
pathogens and also have important immunoregulatory functions. Human NK cells are 
defined as CD56+ and CD3- but recently the marker NKp46 has been described to be 
more convenient over species barriers (Walzer et al, 2007a; Walzer et al, 2007b).  
NK cells develop from a common lymphoid progenitor in the bone marrow and 
represent therefore a third subpopulation of lymphocytes in addition to T and B cells 
(Colucci et al, 2003). Unlike T and B cells, NK cells rely on germ line encoded 
receptors. Due to the lack of somatic recombination of receptor genes and the ability 
to carry out effector functions without sensitization NK cells are defined as a part of 
the innate immune system. They share a bipotential progenitor with T cells, but their 
development is independent of the thymus. The development of NK cells, including 
the formation of the receptor repertoire, the acquisition of self tolerance and effector 
functions, takes place in the bone marrow. The effector mechanisms of NK cells are 
similar to cytotoxic T lymphocytes, and many receptors that were first described on 
NK cells are also expressed on different subsets of T cells. 
NK cells constitute about 5-15 % of all peripheral blood lymphocytes (PBL), represent 
5 % of the lymphocyte population in lymph nodes and are also present in all other 
secondary lymphoid organs. They circulate through other organs like lung and liver. 
Two distinct subsets of mature NK cells have been described that are specialized in 
cytokine production and cytotoxicity. Cytokine production is mainly performed by 
CD56high CD16- cells while CD56dim CD16+ cells are thought to be more cytotoxic 
(Colucci et al, 2003). A specialized subtype of NK cells is found in the decidua during 
pregnancy, probably performing regulatory and antiviral functions (Tabiasco et al, 
2006). In mucosa-associated lymphoid tissues a recently discovered subset of NK 
cells is essential for mucosal homeostasis (Malmberg and Ljunggren, 2009).  
Under certain conditions the amount and distribution of NK cells in the body can 
change. Viral infections result in an expansion of the NK cell population (Dokun et al, 
2001) and NK cells are recruited to the sites of infection (Salazar-Mather et al, 1998) 
or tumor challenge (Smyth et al, 2000). Human NK cells have a turnover time in 
blood of about 2 weeks and proliferation rates appear to fall with ageing (Zhang et al, 
2007). In an adoptive transfer experiment in mice, NK cells were detectable in the 
circulation for about five weeks (Ranson et al, 2003). 
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1.2. NK cell functions 
Morphologically NK cells are characterized as large granular lymphocytes. These 
granules contain perforin and members of the family of granzyme proteases. NK cells 
form conjugates with target cells, resulting in a highly organized structure at the 
contact site called immunological synapse (IS) (Davis, 2002). Formation of an 
activating IS causes polarization of the lytic granules towards the target and 
degranulation of these granules into the synaptic cleft. Subsequently the target cell 
membrane becomes permeable and granzymes can induce apoptosis (Lieberman, 
2003). The ability to kill target cells by this mechanism is of importance for the 
clearance of transformed cells and during the response to various viral infections 
(Cerwenka and Lanier, 2001). NK cells also eliminate cells by triggering death 
receptors on susceptible target cells. They express the tumor necrosis factor (TNF) 
related apoptosis inducing ligand (TRAIL) and Fas ligand (CD178) both belonging to 
the TNF superfamily. If these ligands trigger the respective death receptors they 
induce a signaling cascade that can lead to apoptosis of the target cell (Chavez-
Galan et al, 2009). But NK cells are also necessary during other infectious diseases 
like bacterial infections (e.g. Listeria monocytogenes and mycobacteria) (Kaufmann, 
1993), fungal infections (e.g. Cryptococcus) (Murphy and McDaniel, 1982) and 
parasites (e.g. Leishmania and Toxoplasma) (Korbel et al, 2004). 
The second important effector mechanism of NK cells is the production and release 
of cytokines, mainly interferon (IFN)-γ, TNF-α and granulocyte-macrophage colony-
stimulating factor (GM-CSF) (Biron et al, 1999). In addition to their major role in the 
defense against certain viral infections, NK cell released IFN-γ and TNF-α are also 
important for the development of a protective T cell mediated immunity against 
intracellular pathogens and cancer (Cooper et al, 2004; Moretta, 2002). Such 'helper' 
activity of NK cells is mediated, at least in part, by crosstalk with dendritic cells (DC), 
either by cytokines or direct cell contact (Degli-Esposti and Smyth, 2005). NK cells 
therefore not only act as effector cells, but they also serve an important 
immunoregulatory role (Ferlazzo and Munz, 2004). Despite the expression of the lytic 
machinery, decidual NK cells are less cytotoxic than blood NK cells. Their functions 
are not completely understood, but they play a role in controlling extravillous 
invasion, control of uterine vascular remodeling, and local antiviral activity through 
the productions of large amounts of cytokines (Tabiasco et al, 2006). In mucosa-
associated lymphoid tissues a subset of NK cells expressing the transcription factor 
RORγt has been described recently. These cells have been identified in mice (Luci et 
al, 2009; Sanos et al, 2009) and human (Cella et al, 2009), produce interleukin (IL)-
22 and are essential for mucosal homeostasis and tissue repair.  
1.3. NK cell recognition: 'missing' and 'induced' self 
The discovery of NK cells in the 1970's was based on their ability to lyse allogenic 
tumor cells without prior activation (Herberman et al, 1975a; Herberman et al, 1975b; 
Kiessling et al, 1975a; Kiessling et al, 1975b). The phenomenon of F1 hybrid 
resistance was also established as an NK cell mediated process. But the mechanism 
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how NK cells recognize their targets stayed mysterious until the 'missing-self' 
hypothesis was postulated. Based on the observation, that tumor cells resistant to T 
cell killing were NK susceptible and vice versa, it was hypothesized that NK cells 
detect if major histocompatibility complex (MHC) class I is missing on the target and 
attack these cells with low or no MHC class I expression (Karre et al, 1986; 
Ljunggren and Karre, 1985). This hypothesis was supported by the identification of 
receptors on NK cells that bind to self-MHC class I and are responsible for NK cell 
inhibition (Karlhofer et al, 1992; Moretta et al, 1993). Downregulation of MHC class I 
expression on the cell surface is a common mechanism of many viruses to evade T 
cell recognition and transformed cells often loose MHC class I expression 
completely. These cells therefore are susceptible to NK cell recognition. 
Transplanted grafts that display a different MHC class I pattern than the host are also 
not able to deliver inhibitory signals to NK cells (Ljunggren and Karre, 1990). For 
several years the missing-self hypothesis was the only explanation for NK cell 
activation and specificity. But NK cells also have activating receptors that recognize 
various ligands on target cells. Some of these ligands are upregulated under certain 
conditions and then NK cells can be activated in the presence of inhibitory signals, a 
phenomenon referred to as 'induced-self' (Watzl, 2003). The regulation of NK cell 
function is therefore better characterized as a fine balance of activating and inhibitory 
signals (Fig. 1). 
1.4. Inhibitory NK cell receptors  
The first inhibitory NK cell receptors described were the C-type lectin like Ly49 
receptors in the mouse (Karlhofer et al, 1992) now also called killer cell lectin-like 
receptor family a (Klra). Ly49 receptors are a family of type II transmembrane 
proteins that recognize MHC class I proteins. Some family members have inhibitory 
function as they carry an immunoreceptor tyrosine-based inhibition motif (ITIM) in 
their cytoplasmic tail. Other Ly49 receptors instead interact via a charged amino acid 
in the transmembrane domain with the immunoreceptor tyrosine-based activation 
motif (ITAM) containing adapter molecule DNAX activation protein (DAP)12. These 
receptors therefore are activating, and their ligands are not restricted to MHC class I 
but they can also recognize MHC class I homologue viral ligands (Daniels et al, 
2001; Lee et al, 2001). The recognition of the mouse cytomegalovirus protein m157 
leads to control of the viral infection in mice expressing the respective receptor 
Ly49H (Kielczewska et al, 2007). The first inhibitory receptors characterized on 
human NK cells were type I transmembrane receptors of the Immunoglobulin (Ig)-
superfamily (IgSF), named killer cell Ig-like receptors (KIR) (Wagtmann et al, 1995a; 
Wagtmann et al, 1995b). 
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Figure 1: Illustration of missing and induced self. The NK cell (bottom) can bind with activating and 
inhibitory receptors to the attached target cell (top). The fine balance of inhibitory and activating 
signals can be shifted towards NK cell activation by the loss of inhibitory ligands (missing self) or by 
enhanced expression of activating ligands (induced self) on the target cell. 
The KIR receptors can be divided in two groups, based on their extracellular 
domains: they either contain two (KIR2D) or three (KIR3D) Ig-like domains (Fig. 2). 
Furthermore, similar to Ly49 receptors, they are distinguished by the length of their 
cytoplasmic tail. Those with a long (L) cytoplasmic tail (KIR2DL and KIR3DL) contain 
an ITIM and function as inhibitory NK cell receptors, while those with a short (S) 
cytoplasmic tail (KIR2DS and KIR3DS) deliver activating signals by coupling to 
DAP12. KIR receptors specifically recognize certain human leukocyte antigen (HLA)-
A, -B or -C allotypes, but unlike T cells, this is not peptide specific although the 
peptide contributes to KIR binding (Rajagopalan and Long, 1997). NK cells also 
express inhibitory receptors of the C-type lectin-like family, which are conserved 
between mice and human: NKG2 members forming heterodimers with CD94. The 
NKG2/CD94 complex specifically binds the non-classical MHC class I molecule HLA-
E. The peptides presented by HLA-E are derived from the leader sequence of other 
MHC class I molecules. Only if it binds a peptide, HLA-E is expressed on the cell 
surface. The expression of HLA-E is therefore a marker for the overall expression of 
MHC class I molecules. This receptor complex also comes in inhibitory and activating 
forms: NKG2A and B contain an ITIM in their cytoplasmic domain whereas NKG2C 
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and E couple to DAP12 and can deliver activating signals. The sialic-acid-binding 
immunoglobulin-like lectins (Siglecs) are thought to regulate adaptive and innate 
immune cells. The Siglec receptors 7 and 9 are expressed on NK cells and have 
inhibitory properties (Avril et al, 2004). Probably Siglecs are necessary in regulating 
the tolerance of NK cells towards MHC class I low or negative cells, like cells of the 
nervous system (Crocker et al, 2007). Human NK cells also express one inhibitory 
receptor of the leukocyte immunoglobulin like receptor (LILR) family. LILRB1 binds to 
a conserved region of HLA class I and can inhibit NK cell activation, but the KIR and 
NKG2/CD94 receptors seem to play a more dominant role towards MHC class I 
expressing targets.  
 
Figure 2: Overview of the human inhibitory receptors and their ligands. Inhibitory KIRs and 
NKG2/CD94 complexes carry an ITIM in their cytoplasmic domain. KIRs are receptors of the IgSF that 
bind to different HLA allotypes, while NKG2/CD94 receptors belong to the C type lectin like family and 
recognize HLA-E. 
1.5. Activating NK cell receptors 
The activating NK cell receptors are much more heterogeneous than the inhibitory 
receptors. They cover many different families, use different signaling strategies and 
recognize various ligands. Some of the activating human NK cell receptors do not 
have homologue receptors in the mouse and vice versa, or the homologue receptors 
exhibit distinct signaling properties. This makes it very difficult to compare results 
gained in the two species. The receptors for the 'natural' cytotoxicity (Fig. 3) 
recognize cellular ligands that can be ubiquitously expressed, also on healthy cells, 
or so called induced-self ligands that are upregulated upon cellular stress. The low 
affinity Fc receptor CD16 (FcγRIII) has a unique role in NK cell activation, as it does 
not recognize cellular ligands but antibodies bound to target cells. Engagement of 
CD16 results in antibody-dependent cellular cytotoxicity (ADCC), a mechanism 
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enabling NK cells to support the antigen-specific adaptive immune response 
(Trinchieri and Valiante, 1993). ADCC therefore is not part of the 'natural' cytotoxicity. 
Through this mechanism NK cells also support therapies with monoclonal antibodies, 
e.g. the B-cell non-hodgkin lymphoma targeting antibody rituximab (Anderson et al, 
1997; Reff et al, 1994) as they help eliminating the cells that are recognized by this 
antibody. 
The receptors responsible for natural cytotoxicity include the family of signaling 
lymphocyte activation molecule (SLAM) related receptors (SRR) of which NK cells 
express 2B4 (CD244), CD2-like receptor-activating cytotoxic cells (CRACC/CS1) 
(CD319) and NK, T- and B-cell antigen (NTB-A) (Claus et al, 2008). CRACC and 
NTB-A are homophilic, but 2B4 binds CD48 a glycophosphatidylinositol (GPI) 
anchored protein also expressed on NK cells. SRR have in their cytoplasmic tail so 
called immunoreceptor tyrosine-based switch motifs (ITSM) that can couple to 
activating and inhibitory signaling pathways. But at least in humans the activating 
function of SRR is dominant. Another important group of activating receptors are the 
natural cytotoxicity receptors (NCR) consisting of NKp30 (CD337), NKp44 (CD336) 
and NKp46 (CD335). NKp30 and NKp46 are expressed on all human NK cells, 
currently NKp46 is the most specific marker for human and mouse NK cells (Walzer 
et al, 2007a; Walzer et al, 2007b). NKp44 is expressed on activated human NK cells 
only. Despite their importance for NK cell function, the cellular ligands for NKp44 and 
NKp46 are still unknown. Viral hemagglutinin is recognized by NKp46 and NKp44, 
resulting in enhanced lysis of infected cells (Arnon et al, 2001; Mandelboim et al, 
2001). Human leukocyte antigen-B-associated transcript 3 (Bat3) has been identified 
as cellular ligand for NKp30 (Pogge von Strandmann et al, 2007) and the 
consequences of this interaction are currently under investigation. The NKp30 ligand 
B7-H6 has been described recently and is expressed selectively on tumor cells 
(Brandt et al, 2009). The main tegument protein of human cytomegalovirus (pp65) 
also interacts with NKp30 but results in suppression of NK cell activity (Arnon et al, 
2005), representing an immune evasion strategy by this important pathogen. NCRs 
have no signaling motifs and couple with the ITAM containing adapter molecules 
CD3ζ (NKp30, NKp46), FcεRI-γ (NKp46) and DAP12 (NKp44) (Moretta et al, 2001). 
The receptor NKp80 activates NK cells if it is bound to its ligand activation-induced 
C-type lectin (AICL; also called CLEC2B) (Welte et al, 2006), but the signaling via the 
atypic tyrosine motifs of NKp80 is not understood yet. DNAX accessory molecule 1 
(DNAM-1) binds the molecules poliovirus receptor (PVR) (CD155) and Nectin-2 
(CD112) and also activates NK cells (Gilfillan et al, 2008). The C-type lectin like 
receptor NKG2D has an important role among the activating receptors. The ligands 
identified so far are MHC class I related chain (MIC) molecules A and B and the UL-
16 binding proteins (ULBP). These ligands are of special interest as they are 
upregulated during cellular stress like infection and transformation (Eagle and 
Trowsdale, 2007). While mouse NKG2D is also able to bind DAP12, human NKG2D 
only associates with the DAP10 adapter molecule, which contains an YxNM motif 
instead of an ITAM. The multitude of these receptors is able to activate NK cells on 
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their own, but in a physiological context it is hard to discriminate the contribution of a 
single receptor.  
Integrins like lymphocyte function-associated antigen (LFA)-1 play a special role in 
NK cell activation, as they are necessary for stable adhesion of NK cells to their 
targets. Interaction of LFA-1 with its ligand ICAM-1 is already sufficient to induce 
polarization of granules, but does not trigger NK cell degranulation (Bryceson et al, 
2005). 
 
Figure 3: Overview of activating receptors and their ligands. Signaling motifs of the receptors or their 
respective adapter chains are indicated. CD3ζ is symbolized by ζ and FcεRI-γ by γ. NKG2D interacts 
only with DAP10 on human NK cells. 
1.6. NK cell 'licensing' 
The inhibitory receptors are expressed in a seemingly random manner on NK cells, 
although there is emerging evidence that expression of KIRs is not completely 
stochastic (Andersson et al, 2009) and NKG2A can be upregulated upon NK cell 
activation (Saez-Borderias et al, 2009). As inhibitory receptors were thought to be 
necessary to maintain self-tolerance, the hypothesis was that every NK cell has to 
express 'at least one' self-specific KIR or NKG2A (Valiante et al, 1997). But in 
humans and mice lacking the expression of MHC class I or associated proteins, NK 
cells are not autoreactive, despite the absence of inhibitory ligands (Bix et al, 1991; 
Hoglund et al, 1991). In contrast, they are hyporesponsive to MHC class I deficient or 
mismatched target cells. In humans the subset of mature NK cells, which does not 
express at least one inhibitory receptor is also hyporesponsive (Anfossi et al, 2006). 
These findings led to the hypothesis, that NK cells need to be 'educated' by 
stimulation of inhibitory receptors. Either NK cells are non- or hyporesponsive and 
need the inhibitory signal to become activated (arming model) or they are initially 
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autoreactive, but get anergic in the absence of inhibitory signal (disarming model) 
(Yokoyama and Kim, 2006). Recently it has been demonstrated in mice with various 
MHC class I backgrounds, that this education of NK cells even is dose-dependent. 
The more MHC class I alleles are expressed in the host, the higher is the reactivity of 
these NK cells towards allogenic targets with low or no MHC class I expression 
(Brodin et al, 2009b). Therefore NK cell education has been described to be more 
like a 'tunable rheostat' instead of an on-off switch (Brodin et al, 2009a). One 
possible mechanism for the varying activity of NK cells has been proposed to be the 
cis-interaction of inhibitory receptors with matching MHC class I on the same cell 
(Chalifour et al, 2009). The complete process that matches NK reactivity to self MHC 
class I is only poorly understood and it cannot be excluded, that unknown receptor-
ligand interactions also play a role.  
1.7. Signaling pathways 
The signaling of inhibitory and activating NK cell receptors is depending on tyrosine 
phosphorylation of signaling motifs in the cytoplasmic part of the receptors 
themselves or their adapter proteins. ITAM motifs are phosphorylated by Src family 
kinases (SFK) and then can recruit the kinases Syk and ZAP70. The ITAM initiated 
signals are quite similar to T cell receptor signaling but in contrast to T cells, NK cell 
development is not abrogated in the absence of Syk and ZAP70, and only some 
receptor specific functions are affected (Colucci et al, 2002). Similar observations 
have been made with NK cells lacking all the ITAM containing adapter molecules. 
The receptors belonging to the SRR carry ITSMs that have unique signaling 
properties. Upon phosphorylation ITSMs can recruit the SLAM-associated protein 
(SAP) family of adapters, including SAP, Ewing's sarcoma-activated transcript-2 
(EAT-2), and in mice additionally EAT-2-related transducer (ERT). By binding to 
SAP, SRR are coupled to the Src kinase FynT, which can phosphorylate the 
receptors as well as transmitting the activating signal to downstream effectors. ITSMs 
can also exhibit an inhibitory function by recruiting the SH2 containing protein 
tyrosine phosphatases (SHP)-1, SHP-2 and the inositol phosphatase SHIP 
(Eissmann et al, 2005). If triggering of SRR results in activation or inhibition is 
critically dependent on the adapter molecules accessible (Wahle et al, 2007), but the 
mechanism is only partially understood (Veillette, 2006). The adapter molecule 
DAP10, which associates with NKG2D, carries an YxNM motif that is typical for 
costimulatory receptors e.g. CD28, but NKG2D engagement alone is sufficient for NK 
cell activation. After NKG2D triggering DAP10 binds the p85 subunit of 
phosphatidylinositol-3-kinase (PI3K), but PI3K alone cannot initiate the full signal 
necessary for effector functions. Additionally DAP10 can recruit complexes of the 
adaptor molecule growth factor receptor-bound protein (Grb)2 and Vav1, leading to 
Vav1 activation (Upshaw et al, 2006). There are functional redundancies between the 
Vav family members Vav1, 2 and 3. In NK cells Vav proteins are indispensable for 
ADCC and natural cytotoxicity initiated by distinct NK cell receptors (Cella et al, 2004; 
Colucci et al, 2001). To release Vav1 from its autoinhibitory conformation regulatory 
tyrosines in the acidic region have to be phosphorylated (Aghazadeh et al, 2000). 
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First, the N-terminal Y142 and Y160 are phosphorylated, to enable SFKs to bind to 
Vav1 and phosphorylate Y174 blocking the Dbl homology (DH) domain 
(Amarasinghe and Rosen, 2005). If these tyrosines are phosphorylated the DH 
domain is accessible and Vav1 can perform its function as a guanine exchange 
factor (GEF) for the small Rho family guanosine triphosphatase (GTPases) Rac1 and 
Cdc42 (Billadeau et al, 1998; Galandrini et al, 1999). Like all members of the Dbl 
family, Vav proteins also contain a Pleckstrin-homology (PH) domain that can bind 
PI3K generated lipid products. The mechanism by which the PH domain influences 
the GEF activity of Vav is controversial. Activation of the small GTPases has multiple 
downstream effects, e.g. the reorganization of the actin cytoskeleton. The induction 
of actin reorganization is essential for the formation of the IS. The actin driven 
clustering of activating receptors at the contact area between NK and the target cell 
(Orange, 2008) can enhance the activating signal. The process of activating receptor 
clustering is paralleled by clustering of cholesterol-enriched membrane microdomains 
(lipid rafts) at the IS (Fassett et al, 2001; Lou et al, 2000). The recruitment of 
activating receptors such as NKG2D or 2B4 to membrane microdomains seems to be 
crucial for the phosphorylation and function of these receptors (Endt et al, 2007; 
Watzl and Long, 2003). SFKs are also enriched in membrane microdomains through 
the post-translational addition of a lipid anchor (Shenoy-Scaria et al, 1993). The 
activity of these kinases can be enhanced by phosphorylation of a tyrosine in the 
activation loop and inhibited by phosphorylation of a C-terminal tyrosine. The 
phosphatase CD45 is required for dephosphorylation of this inhibitory tyrosine 
(McNeill et al, 2007), thereby maintaining a pool of active SFKs. But CD45 may also 
play a role in dephosphorylating the activating tyrosines of receptors, adaptors and 
signaling molecules. As postulated by the kinetic-segregation model (Davis and van 
der Merwe, 2006), CD45 and other bulky phosphatases such as CD148 are excluded 
from the close contact in the IS. This would further enhance the phosphorylation of 
activating NK cell receptors and their downstream mediators. 
Inhibitory receptors can regulate the activity of a variety of activating receptors 
coupling to diverse signaling pathways. Therefore the question arises if they employ 
different inhibitory mechanisms for different receptor signaling pathways or if they 
interfere with a central signaling event common to all activating receptors. Upon 
engagement with MHC class I molecules, inhibitory receptors get tyrosine 
phosphorylated on ITIMs in their cytoplasmic tails. The phosphatases SHP-1 and 
SHP-2 are recruited to these ITIMs (Long et al, 2001). The binding increases the 
activity of the phosphatases (Hof et al, 1998), which might further be stabilized by 
phosphorylation (Lu et al, 2001). Active SHP-1 can interfere with early events of NK 
cell activation. Vav1 has been identified as a direct target for SHP-1 when recruited 
by an inhibitory NK cell receptor (Stebbins et al, 2003), and may represent the first 
step at which activating and inhibitory signals converge. Dephosphorylation of Vav1 
would block the actin dependent recruitment of activating receptors to specialized 
membrane domains (Watzl et al, 2003). Thereby they stop the activating feedback 
loop initiated by the phosphorylation of activating receptors followed by Vav1 
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phosphorylation, recruitment and phosphorylation of more activating receptors (Watzl 
et al, 2000). This process of NK cell inhibition is spatially restricted to the site of the 
inhibitory IS, enabling NK cells to recognize and attack target cells lacking inhibitory 
ligands while being inhibited by other contacts (Eriksson et al, 1999).  
 
Figure 4: Crosstalk between activating and inhibitory signals. Upon triggering of activating receptors 
Vav1 gets phosphorylated and initiates a positive feedback loop of actin reorganisation and 
recruitment of more activating receptors. Inhibitory receptors can block phosphorylation of Vav1 via 
the phosphatase SHP-1.  
If the inhibitory signal cannot overcome the activating signal, downstream mediators 
get initiated. Phosphoinositide 3-kinase (PI3K) can be activated directly upon NKG2D 
triggering by interacting with DAP10, or via Syk or ZAP70 after triggering of receptors 
that use ITAMs. Active Vav1 acts as a GEF and activates Rac1 (Galandrini et al, 
1999). As Vav1 and PI3K both interact with DAP10 and are activated directly upon 
NKG2D triggering, it is hard to differentiate the sequence of events. In mice lacking 
Vav1 it has been shown, that Akt phosphorylation is impaired, indicating that Vav1 is 
required for PI3K activation upon NKG2D stimulation (Graham et al, 2006). The p21-
activated kinase (PAK1) acts downstream of Rac1 and is responsible for the initiation 
of the mitogen activated protein kinase (MAPK) cascade including MAPK kinase 
(MEK) and extracellular signal-regulated kinase (ERK). Phosphatidylinositol-specific 
phospholipase C-γ (PLC-γ) enzymes are indispensable components of signal 
transduction complexes downstream of a number of immune receptors. PLC-γ 
cleaves phosphatidylinositol (PI) 4,5-bisphosphate (PI4,5P2) into inositol 1,4,5-
trisphosphate (IP3) and 1,2-diacyl-glycerol (DAG). IP3 induces the opening of 
intracellular Ca2+ stores leading to a rise in intracellular Ca2+ concentration, whereas 
DAG activates the protein kinase C (PKC) and the Ras pathways. The Ca2+ release 
by PLC-γ is necessary for the secretion of cytotoxic granules, but not for conjugate 
formation and polarization of actin and the microtubule-organizing center (MTOC) 
towards the target cell (Caraux et al, 2006). The Ca2+ signal and the MAPK cascade 
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are essential for the initiation of effector functions of NK cells, but probably not 
involved in the primary integration of activating and inhibitory signals. 
Given the importance of regulating immune cell responses by a balance of positive 
and negative signals, it is mandatory to better understand the integration of these 
opposing signals on a molecular level. NK cell activation is strictly dependent on such 
a balance of positive and negative signals mediated by many different surface 
receptors.  
1.8. Revealing signaling dynamics by mathematical modeling 
Systems biology is an integrative discipline combining modeling approaches and 
experiments. With classical methods like biochemistry many aspects of the signaling 
of immune cells have been studied. But as the network is so complex the impact of a 
single molecule or one defined protein interaction is hard to estimate. Used 
appropriately, mathematical models can represent pathways in a physically and 
biologically realistic manner. Therefore a mathematical model could support the 
understanding of the decision making process of NK cells.  
The methods that can be applied to construct a model are very diverse. Depending 
on the biological system, the question that has to be solved and the data available, 
different models can be generated. Qualitative molecular reactions and signaling 
pathways modeled as static networks or boolean networks are often used to get an 
overview in large systems, when little or no quantitative information is available. But 
as in these systems every element exists only in two states (yes/no) concentration 
dependent dynamics and kinetics cannot be simulated. As the decision making of NK 
cells is critically depending of the strength of two opposing signals, these qualitative 
models are not suitable to solve our question. In quantitative mathematical models 
each equation refers to identifiable processes (such as catalysis and assembly) and 
parameters have physical interpretation (such as concentration, binding affinity and 
reaction rate). These models work best with pathways that are well studied, as 
information about molecule concentrations and reaction parameters are necessary 
(Aldridge et al, 2006). As the quantitative approach is able to reveal dose-responses 
and kinetics, it is appropriate to describe the balance of NK cell activation. When 
limited mechanistic knowledge or conflicting hypotheses hamper the development of 
predictive mechanistic models, ‘ensemble modeling’ can be performed (Kuepfer et al, 
2007). As several concepts have been proposed to influence the signaling of immune 
receptors, ensemble modeling can be useful to distinguish between the effects of 
these concepts. In addition to one core model several optional reaction modules can 
be included. The effects of these optional modules on the simulation results can 
elucidate which reactions are of special importance for a physiologic response of the 
system. 
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2. Aim of the thesis 
The signal integration of NK cells is able to transform the gradual signal input through 
a variety of activating and inhibitory receptors into a decision to kill or spare the target 
cell. The mechanisms regulating this balance of positive and negative signals are 
only poorly understood. To gain better insight into the signal integration on the 
molecular level, we chose a systems biology approach. In cooperation with the group 
of Roland Eils of the division of Theoretical Bioinformatics from the DKFZ we wanted 
to create a mathematical model describing the receptor proximal signal transduction 
network of NK cells. By comparing the simulation results of this model with 
experimental data we aimed to reveal the mechanisms of the decision making of NK 
cells.  
We propose a model, which integrates the activating and inhibitory signals on the 
level of the GEF Vav1, as it is an early target of both pathways. By using 'ensemble 
modeling' we created a family of simplified models. Each module of the model 
family addresses one concept of immune receptor signaling, that has been 
proposed to be important for signal regulation. Among these different concepts we 
aimed to identify the reactions that play key roles during the integration of activating 
and inhibitory signals. As we wanted to establish a mathematical model based on 
differential equations we needed to quantify concentrations of the proteins involved 
in the reactions of the model. Based on these quantifications and information from 
the literature we were able to simulate the phosphorylation of Vav1 with the model 
family. Then experimental data about the Vav1 phosphorylation was compared to 
the simulation results derived from the models containing the reactions that 
addressed the different signaling concepts. This analysis should reveal the key 
concepts necessary for a physiological response of the model on the level of Vav1. 
With the model containing the essential reactions we could make additional 
predictions concerning manipulations and perturbances of the system. Testing 
these predictions experimentally could show the validity and the reliability of our 
simulations. Furthermore we wanted to investigate the cytotoxic activity of NK cells 
differentially stimulated via activating and inhibitory receptors, to uncover how the 
signal integration on the level of Vav1 contributes to a reliable killing decision of the 
NK cell. 
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3. Materials and Methods 
3.1. Materials 
3.1.1. Mouse monoclonal antibodies 
Name Source, Reference 
IgG control, MOPC21 Sigma, Taufkirchen, Germany 
anti-NKG2D (149810) RnD Systems, Minneapolis, USA 
anti-NKG2D (3.1.1.1) (Endt et al, 2007) 
anti-NKG2A/CD159a (Z199) 
anti-CD94 (HP-3B1) 
anti-KIR2DL1 (EB6) 
anti-KIR2DL2/3 (GL183) 
anti-2B4 (C1.7) 
Beckman Coulter, Fullerton, USA 
anti-Vav1 (VAV-30) Abcam, Cambridge,  USA 
anti-Vav Millipore, Billerica, USA 
anti-SHP-1 BD Transduction Laboratories, Franklin 
Lakes, USA 
anti-non-phospho-Src (7G9) (Tyr416) Cell Signaling Technologies, Danvers, USA 
anti-Fyn (25) BD Transduction Laboratories 
anti-Lck Abnova 
3.1.2. Rat monoclonal antibodies  
Name Source, Reference 
anti-human DAP10 (4E1) a gift of E. Vivier, Centre d'Immunologie de 
Marseille-Luminy, France 
3.1.3. Rabbit polyclonal antibodies  
Name Source, Reference 
anti-phospho Vav1 pY 160 Biosource, Camarillo, CA 
anti-Actin Sigma 
anti-Fyn Cell Signaling Technologies 
anti-phospho-Src family pY416 Cell Signaling Technologies 
anti-Lck a gift of A. Veillette, Clinical Research 
Institute of Montreal, Canada 
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3.1.4. Secondary antibodies 
Name Source, Reference 
goat-anti-mouse IgG unlabeled 
goat-anti-mouse IgG PE / Cy3 
goat-anti-mouse IgG HRPO 
goat-anti-rat IgG HRPO 
Jackson ImmunoResearch Laboratories, 
West Grove, PA 
goat-anti-rabbit IgG HRPO Santa Cruz Biotechnology, Heidelberg, 
Germany 
3.1.5. Recombinant Proteins 
Name Tag, Size Source 
Lck GST, full length, 85 kDa Abnova 
SHP-1 GST, full length, 95 kDa Millipore 
N-Vav1 His, N terminal 58 kDa this work 
3.1.6. Bacteria 
E.coli strain Use Source 
TOP10 amplification of plasmids Invitrogen, Carlsbad, CA 
BL21 (DE3) pLys expression of proteins Invitrogen 
3.1.7. Cells (eukaryotic) 
All media were purchased from Gibco (Invitrogen, Carlsbad, CA); Fetal calf serum 
(FCS), Non essential Amino Acids and Pyruvate was from Gibco, human serum from 
PromoCell (Heidelberg, Germany), PHA-P from Sigma and purified human IL-2 from 
Hemagen Diagnostics (Columbia, USA). If not indicated otherwise all cells were 
grown with 10 % (v/v) FCS and 1 % (v/v) Penicillin/Streptomycin (Gibco, Invitrogen).  
 
Cell type Origin Culture medium 
NKL human NK cell line RPMI, 100 U/ml IL-2 
human peripheral blood 
lymphocytes 
isolated from whole blood or 
buffy coats 
 
primary human NK cell 
populations (NK pop) 
isolated from human 
peripheral blood 
lymphocytes 
NK pop medium: IMDM, 
10 % (v/v) human serum, 
10 % (v/v) Non essential 
Amino Acids, 10 % (v/v) 
Pyruvate, 100 U/ml IL-2 
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primary human NK cell 
clones 
expanded from primary 
human NK cell populations 
cloning medium: IMDM, 
10 % (v/v) human serum, 
10 % (v/v) Non essential 
Amino Acids, 10 % (v/v) 
Pyruvate, 100 U/ml IL-2, 
10 % (v/v) purified human 
IL-2, 1 µg/ml PHA-P  
JY B cell lymphoblastoid cell 
line 
RPMI, 50 µM 2-
Mercaptoethanol 
P815 mouse mastocytoma cell 
line 
IMDM 
3.1.8. Buffers 
Triton X-100-lysis buffer:  150 mM NaCl 
 20 mM Tris-HCL, pH 7.4 
 10 % (v/v) Glycerol 
 0.5 % (v/v) Triton X-100 
 2 mM EDTA 
 10 mM NaF 
 1 mM PMSF 
 1 mM Na-orthovanadate (for studies 
on protein phosphorylation) 
 
Brij58-lysis buffer:  150 mM NaCl 
 20 mM Tris-HCL, pH 7.4 
 10 % (v/v) Glycerol 
 0.5 % (v/v) Brij58, AppliChem, Darmstadt 
 2 mM EDTA 
 10 mM NaF 
 1 mM PMSF 
 1 mM Na-orthovanadate (for studies 
on protein phosphorylation) 
 200 Kunitz 
Units 
DNase (Sigma) 
PBS (pH 7.4): 137 mM NaCl 
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 8.1 mM Na2HPO4 
 2.7 mM KCl 
 1.5 mM KH2PO4 
 
PBST: 1 x  PBS 
 0.05 % (v/v) Tween 20 
 
PBST/NaCl: 1 x  PBS 
 0.05 % (v/v) Tween 20 
 0.5 M NaCl 
 
1 x  PBST Blocking Buffer for western Blot: 
5 % (w/v) nonfat dry milk powder, Saliter, 
Obergünzburg 
 
PBS/pervanadate: 1 x  PBS 
 10 mM  H2O2 
 200 µM Na-orthovanadate 
 
Western blot transfer buffer: 24 mM Tris 
 129 mM Glycin 
 20 % (v/v) MeOH 
 
Reducing sample buffer (5 x): 10 % (w/v) SDS 
 50 % (v/v) Glycerol 
 25 % (v/v) 2-Mercaptoethanol 
 0.1 % (w/v) Bromphenol Blue 
 0.3125 mM Tris-HCL, pH = 6.8 
 
200 mM Glycin Stripping buffer (pH 2.2) for 
western Blot: 0.1 % (w/v) SDS 
 1 % (v/v) Tween 20 
MATERIALS AND METHODS 
 
22 
DNA-sample buffer (6 x): 0.25 % (w/v) Bromphenol Blue 
 0.25 % (w/v) Xylene Cyanol FF 
 30 % (v/v) Glycerol in H2O 
 
Protein purification:   
Lysis buffer pH 8 6 M Guanidin Hydrochlorid 
 0.1 M Na2HPO4 
Elution buffer pH 4 6 M Guanidin Hydrochlorid 
 0.1 M Na2HPO4 
 
Ca2+ assay:   
wash medium 2.5 mM Probenicide (500 mMin 1 M 
NaOH) 
 5 mM HCl 
 10 % (v/v) FCS 
 1 % (v/v) Penicillin/Streptomycin 
  in IMDM 
assay medium 500 mM Probenicide (in 1 M NaOH) 
 5 mM HCl 
 10 mM HEPES 
  in HBSS 
loading medium 4.8 µM Fluo4 
 0.16 % (v/v) Pluronic acid 
  in wash medium 
 
MOPS buffer (20 x) Invitrogen  
TAE (10 x) Invitrogen  
3.1.9. Reagents 
Agarose, Gibco, Paisley, Scotland  
Ampicillin, Roth, Karlsruhe, Germany  
BSA, Serva, Heidelberg, Germany  
5-Bromo-4-chloro-3-indoxyl-β-D-galactoside (X-Gal), Roth 
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Choleratoxin B subunit (Alexa488), Calbiochem, Beeston, England  
Chromium-51, Hartmann Analytik, Braunschweig  
Complete protease inhibitor mix, Roche, Mannheim, Germany 
DNA ladder (100 bp and 1kb), Invitrogen  
Dynabeads Protein G, Dynal, Invitrogen 
Inhibitors (Piceatannol, PP1, Wortmannin, Cytochalasin D, Latrunculin, PD-98059, 
SB-202190, U73343, U73122), Biomol, Hamburg, Germany  
Isopropyl-β-D-thiogalactopyranoside (IPTG), Roth 
Kanamycin, Roth 
LB broth, Invitrogen  
LSM solution, PAA, Pasching, Germany 
Ni2+-NTA Agarose Qiagen, Hilden, Germany  
Poly-L-Lysine, Sigma 
Precision Plus Protein Standard, BioRad, Hercules, CA  
Protein G agarose, Invitrogen  
Streptavidin-HRPO, Jackson ImmunoResearch Laboratories 
SuperSignal West Pico and Dura, Thermo 
X-ray films, Perbio/Pierce, Rockford, IL 
3.1.10. Vectors 
Name Use Source 
pCR2.1-TOPO subcloning of PCR products Invitrogen 
pRSetB expression of His tagged proteins Invitrogen 
3.1.11. Enzymes 
Name Use Source 
restriction endonucleases DNA digest 
T4 DNA ligase DNA ligation 
Taq DNA Polymerase PCR 
New England Biolabs, 
Frankfurt, Germany 
AMV reverse transcriptase (RT) RT-PCR First strand cDNA synthesis 
kit, Roche Diagnostics 
All enzymes were used in buffers provided by the manufacturer. 
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3.1.12. Oligonucleotides 
Name Use Sequence (5'-3') 
Vav N fw ggatccagagctgtggcgccaatg 
Vav N rev 
amplification of N-Vav1 
gaattctcactcggtctcctgaagagtc 
3.1.13. Kits 
Isolation of RNA: RNeasy Mini Kit, Qiagen 
Plasmid DNA purification: Plasmid Mini Kit, Plasmid Midi Kit, Qiagen 
DNA Fragment Purification: Gel Extraction Kit, Qiagen 
Quantification of surface receptors: Qifikit, Dako 
Quantification of SHP-1 activity: DuoSet IC, Human/Mouse/Rat Active SHP-1 Activity 
Assay, R&D 
Quantification of protein concentration: EZQ Protein Quantitation Kit, Molecular 
Probes, Invitrogen 
3.2. Methods 
3.2.1. Molecular biology  
Isolation of RNA 
RNA was isolated from IL-2 expanded primary human NK populations using the 
RNeasy Mini Kit according to the manufacturers instructions. 
Reverse Transcription 
RNA was transcribed to cDNA using the First strand cDNA synthesis kit. 1 µg or 2µg 
RNA were used as template, the reaction was performed according to the 
manufacturers instructions. 
Polymerase chain reaction (PCR)  
PCR was used to amplify DNA fragments from cDNA. The conditions were fit to the 
respective need.  
Isolation of Plasmid DNA  
Bacteria were grown in 1 x LB medium with the appropriate selective antibiotic at 
37°C over night. After harvesting the bacteria by centrifugation at 3500 g for 5 min, 
DNA was isolated according to the manufacturers instructions, using either the 
Plasmid Mini or Midi Kit from Qiagen.  
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Ligation of DNA  
The insert and the vector DNA were mixed at a ratio of approximately 3:1 in ligation 
buffer. The mixture was incubated with 2U T4 DNA ligase for 1h at room temperature 
or overnight at 16°C and used for the transformation of competent bacteria.  
Transformation of bacteria  
All bacteria were chemically competent. Transformation was done according to the 
manufacturers instructions. Bacteria were grown on LB-agar plates at 37 °C for 24h 
and selected with the appropriate antibiotic.  
Agarose gel electrophoresis  
The DNA solution was mixed with DNA sample buffer before loading the gel. 1 % 
gels were used for optimal separation of the fragments (TAE, agarose, 0.00001 % 
Ethidiumbromide). The correct size of the DNA fragment was controlled using a DNA 
ladder.  
DNA digest  
Between 1 and 2 µg of DNA were incubated with 2 U of the respective restriction 
endonuclease for at least 1h at 37°C. Conditions of the reaction were set according 
to the manufacturers instructions. The DNA fragments were separated by agarose 
gel electrophoresis.  
Isolation of DNA fragments from agarose gels  
DNA fragments were excised from the agarose gel and the DNA was extracted using 
the Qiagen gel extraction kit according to the manufacturers instructions. 
3.2.2. Cell biology  
Cell culture  
All cells were grown at 37°C and 5 % CO2 in a humidified incubator under sterile 
conditions. Cells lines were split on a regular basis every two to three days. Cell 
culture flasks were exchanged every week. Cells were frozen in FCS containing 
10 % DMSO at -75°C and stored in liquid nitrogen. Cell lines were thawed on a 
regular basis. FCS and human serum were heat inactivated by incubation on 56°C 
for 30 min prior to use.  
NK cell isolation  
Human polyclonal NK cells were isolated from whole blood or buffy coats. First 
peripheral blood mononuclear cells (PBMC) were purified by density centrifugation 
over LSM solution. Then NK cell were isolated using the NK cell negative isolation kit 
from Dynal (Invitrogen). NK cells were between 90 % and 99 % NKp46+, CD3- and 
CD56+. After isolation NK cells were plated on 96 well round bottom plates at 1x106-
2x106 cells/ml with 5x105 cells/ml irradiated JY cells. Growing cells were expanded 
1:1 with NK pop medium. 
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Expansion of NK cell clones 
NK clones were generated by limiting dilution of fresh NK cells in cloning medium 
containing 5x105 cells/ml irradiated feeder cells (1:1 ratio of JY cells and allogenic 
PBMC). After 7 days clones were re-stimulated with 50 % fresh cloning medium and 
feeder cells. Growing clones were expanded 1:1 with NK pop medium. 
Cell stimulation  
Antibody crosslinking  
Cells were resuspended at 2x107 cells/ml in medium supplemented with 100 U/ml 
recombinant IL-2. Samples were incubated at room temperature (RT) for 10 min after 
adding the respective amounts of primary antibody. Samples were washed with 
500 µl medium, pelleted by centrifugation for 5 min at 500 g at RT, and again 
resuspended at 4x107 cells/ml in medium containing IL-2. Cells were then transferred 
to 37°C and the same volume of prewarmed 10 µg/ml solution of secondary antibody 
in medium was added for the indicated times. Stimulation was stopped by putting the 
cells immediately on ice and washing with 500 µl ice cold medium. Cells were 
pelleted by centrifugation for 5 min at 500 g at 4°C and lysed.  
Bead stimulation  
Dynabeads were washed 3 times with medium and resuspended in the initial volume. 
Human-anti-mouse coupled Dynabeads contained 4x105 beads/µl. Then the 
indicated amount of mouse antibody was added and incubated for 1 h at room 
temperature. After 3 washes, the Dynabeads were resuspended at 4x107 beads/ml in 
medium supplemented with 100 U/ml recombinant IL-2. Cells were also resuspended 
at 4x107 cells/ml. Cells were then transferred to 37°C and the same volume of 
prewarmed Dynabeads suspension was added for the indicated times. After 
stimulation cells were immediately chilled on ice and washed with 500 µl ice cold 
medium. Cells were pelleted by centrifugation for 5 min at 500 g at 4°C and lysed.  
Inhibitor pretreatment  
To inhibit signaling processes cells were treated for 30 min at 37°C with the 
respective inhibitors at 2x107 cells/ml in medium supplemented with 100 U/ml. 
Unless indicated otherwise, the following concentrations were used: 50 µM 
Piceatannol, 10 µM PP1, 100 nM Wortmannin, 20 µM PD-98059, 100 nM SB-202190 
and 1 µM U-73122. During the following stimulation of these cells the inhibitor 
concentration was kept constant. Protein phosphorylation was induced by using the 
phosphatase inhibitor pervanadate. Cells were resuspended at 2x107 cells/ml in 
PBS/pervanadate solution and incubated for 10 min at 37°C.  
Cell lysis  
For western blot analysis 1-4x107 cells/ml were lysed to obtain the required protein 
concentrations. Pelleted cells were resuspended in 0.5 % Triton X-100 lysis buffer 
supplemented with 1 mM PMSF and if necessary 1 mM Na-orthovanadate and 
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incubated on ice for 20 min. Lysates were clarified by centrifugation for 15 min at 
20000 g and 4°C.  
Chromium-release assay 
The medium was always supplemented with recombinant IL-2 to a final concentration 
of 100 U/ml. Cell lines were grown to mid log phase, primary NK clones were used at 
3-4 weeks age. Antibody dilutions were prepared in medium on a 96 V-well plate. 
Usually 5x104 NKL or 1x104 primary NK cells per well were mixed with the prepared 
antibody dilutions. 5 x105 P815 target cells were labeled in 100 µl medium with 
100 µCi 51Cr (3,7 MBq) for 1 h at 37°C. Cells were washed twice in medium and 
resuspended at 5x104 cells/ml in medium. 5000 target cells/well were used in all 
assays. Maximum release was determined by incubation of target cells in 1 % Triton 
X-100. For spontaneous release, targets were incubated without NK cells in medium 
alone. All samples were done in triplicates. Plates were incubated for 4 h at 37°C, 
5 % CO2. Supernatant was harvested and 51Cr release was measured in a gamma 
counter. Percent specific release was calculated as ((experimental release - 
spontaneous release) / (maximum release - spontaneous release)) x 100. When the 
inhibitor PP1 was used effector cells were pre-incubated with the inhibitor for 30 min 
at 37°C, 5 % CO2 before target cells were added.  
Ca2+ measurement 
NKL cells were resuspended at 1x107 cells/ml in loading medium and incubated for 
30 min at 37°C, washed twice with wash medium, rested for 30 min at 37°C in wash 
medium and were washed again. Cells were resuspended at 1x106 cells/ml in wash 
medium and preincubated with the indicated primary antibodies for 10 min at RT on a 
96 V-well plate and washed to remove excess antibody. Cells were mounted in assay 
medium and transferred to a 96 well flat bottom plate. The plate was measured 
immediately in a plate reader (Wallach Victor2, 1420 Multilabel Counter, Perkin 
Elmer) at 488 nm excitation and 525 nm emission to obtain the baseline of the Ca2+ 
signal. Then crosslinking antibody was added to all wells to a final concentration of 
5 µg/ml, mixed gently and measured again in the plate reader. All samples were 
done in triplicates. 
Flow cytometry 
Cell staining 
Surface staining of cells was performed in 96 V-well plates. About 2x105 cells were 
resuspended in 50 µl fluorescence-activated cell sorting (FACS)-buffer (PBS 
containing 2 % FCS) containing 10 µg/ml of the respective primary antibody and 
incubated on ice for 20 min. After washing with FACS-buffer cells were resuspended 
in 50 µl PE conjugated goat-anti-mouse secondary antibody diluted 1:200 in FACS-
buffer. Cells were incubated on ice for 20 min in the dark to protect the fluorophore, 
washed again and resuspended in FACS-buffer containing 2 % formaldehyde. 
Samples were analyzed on a BD FACScan or BD FACScalibur and results were 
evaluated using the FlowJo Software from Treestar. 
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Quantification of surface molecules 
Surface molecules were quantified using the Qifikit (Dako) according to the 
manufacturers instructions. In brief, cell staining was performed as described but 
additionally calibration beads were stained with the same solution of secondary 
antibody. Based on the mean fluorescence intensity (MFI) of the calibration bead 
populations a standard curve was generated and used to calculate molecule 
numbers on the stained cells. 
Confocal microscopy 
Imaging of cells stimulated by receptor crosslinking 
NKL cells were resuspended at 2x107 cells/ml in medium supplemented with 
100 U/ml recombinant IL-2. Cells were stimulated as described, but for receptor 
crosslinking 7 µg/ml Cy3 conjugated goat-anti-mouse antibody were used and cells 
were incubated for 5 min on ice with the secondary antibody prior to crosslinking. 
After stimulation cells were immediately fixed by adding the equal volume of 4 % 
Paraformaldehyde solution and incubation for 15 min at RT. Cells were washed once 
with PBS and resuspended at 1.5x105 cells/ml in PBS. 200 µl of this solution 
(=30 000 cells) were centrifuged onto Poly-L-Lysine (PLL) (Sigma) coated coverslips. 
Coverslips were incubated for 5 min in 0,1 TritonX-100 solution to permeabilize the 
cells. Then the coverslips were washed twice with FACS buffer, with 10 min 
incubation to block unspecific binding in the following staining. Cells were incubated 
with Alexa488 conjugated phalloidin (Molecular Probes) for 20 min at RT, washed 3 
times in PBS and finally in H2O. When the coverslips were dry, they were mounted 
using Mowiol (Calbiochem) and imaged on a Leica DMRBE. 
Imaging of cell-bead conjugates 
Antibody coated Dynabeads were prepared as described and mixed at a 1:1 ratio 
with NKL cells at a concentration of 2x106 cells/ml. 100 µl of this mix (=2x105 cells) 
were incubated for 30 min at 37°C on PLL coated coverslips. Cells were fixed as 
described above and stained with Alexa488 conjugated CTX for 20 min at RT. Then 
cells were washed, permeabilized and blocked as described. Finally cells were 
stained with TRITC labeled phalloidin, washed and mounted as above.  
3.2.3. Protein biochemistry 
Production of recombinant protein 
To produce a His-tagged N-terminal part of Vav1 (amino acids 2-462) we amplified 
the respective sequence using cDNA from primary human NK cells and sub-cloned it 
into the pRSet B Vector (Invitrogen). The Vector was transformed into E. coli BL21 
(DE3) pLys (Invitrogen). Bacteria were grown with shaking at 37°C to OD600 0.7, 
induced with 0.5 mM IPTG and incubated for additional 3 h. Then bacteria were 
pelleted and 500 ml culture were lysed in 100 ml protein purification lysis buffer (pH 
8) for 60 min with agitation at RT. Lysates were clarified by 30 min centrifugation at 
20000 g. 2 ml Ni2+ NTA agarose beads were washed two times with lysis buffer, 
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added to the lysates and incubated with agitation for 2 h. The beads were extensively 
washed with lysis buffer and applied to a PolyPrep chromatography column (Biorad). 
Proteins were eluted by adding 5 ml protein purification elution buffer (pH 4) to the 
column and fractions were collected. Fractions containing the maximum yield were 
pooled and dialyzed against 10 mM Tris (pH 8.8). If necessary, precipitated protein 
was dissolved by adding SDS to a final concentration of 0.1 %. For storage, 1 mM 
PMSF was added, and protein solution was frozen in aliquots at -20°C. 
Protein quantification  
Protein concentration was determined using a customized BSA standard and the 
EZQ Kit according to the manufacturers instructions. The membrane was analyzed 
on a FLA-2000 (Inter Departmental Equipment, Haifa, Israel) using 473 nm excitation 
wavelength and 580 nm emission filter. 
Immunoprecipitation 
For immunoprecipitations stimulated cells were lysed in Brij58-lysis buffer at a 
concentration of 2x107 cells/ml. The non-clarified lysates were incubated with gentle 
agitation with 5 µg/ml goat-anti-mouse for 20 min at 4°C, then 12.5 µl Protein G 
Dynabeads (Invitrogen) were added for 2 h at 4°C. Beads were washed at least 5 
times with lysis buffer. Proteins were eluted from the beads with 50 mM glycine (pH 
2) and the eluates were neutralized with 1 M NaOH prior to SDS-PAGE.  
SDS-Polyacrylamid gel electrophoresis (SDS-PAGE) 
After adding reducing sample buffer, samples were boiled for 5 min at 95°C and 
centrifuged for 1 min at 20000 g. Samples to a maximal volume of 25 µl and 5 µl of 
Precision Plus Protein Standard (BioRad) were loaded on 10 % or 4-12 % NuPage 
gels (Invitrogen) and separated for 1 h 15 min at 150 V in 1 x MOPS buffer. 
Western Blot 
After SDS-PAGE proteins were transferred to a polyvinylidene difluoride (PVDF) 
membrane (Millipore) for 1.5 h at 200 mA in western blot transfer buffer. PVDF 
membranes were activated with methanol and washed with transfer buffer prior to 
use. After western blotting, membranes were incubated for 1 h at RT in blocking 
buffer and washed for at least 3 times in PBST. Membranes were incubated with the 
primary antibody for 1 h at RT or overnight at 4°C. The membrane was washed at 
least three times with PBST/NaCl and incubated with the appropriate horseradish-
peroxidase (HRPO)-conjugated secondary antibody for 1 h at room temperature. 
Secondary antibodies were diluted 1:5 000-1:40 000 in blocking buffer. After 
incubation with the secondary antibody, the membrane was extensively washed with 
PBST and developed using either SuperSignal West Pico or Dura and X-Ray films. 
The films were quantified using a densitometer (GS 800, Biorad). 
Coomassie staining  
Gels were washed three times for 5 min in deionized water, incubated for 30 min or 
longer with SimplyBlue Safe stain (Invitrogen) or Imperial stain (Pierce) for higher 
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sensitivity on a shaking incubator and washed again. Gels were scanned on a 
densitometer (GS 800, Biorad).  
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4. Results 
4.1. Establishing the experimental and the mathematical system 
4.1.1. Vav1 phosphorylation induced by NKG2D triggering 
As we wanted to test the signal integration of activating and inhibitory receptors on 
the level of Vav1, we needed a suitable experimental system to test our simulation-
derived predictions. Expression of the receptors on primary human NK cells is very 
heterogeneous between different donors and among the cell population of one donor. 
We chose the activating receptors NKG2D and 2B4 for stimulation of the cells, as 
these receptors are expressed on all primary human NK cells and the NK cell line 
NKL and they are known to be strong activators of cytotoxicity. The inhibitory 
receptor complex NKG2A/CD94 is more frequently expressed on primary human NK 
cells than KIR receptors, and also expressed on NKL cells. In contrast to stimulating 
the NK cells with ligand expressing target cells, antibody crosslinking offers the 
possibility to trigger defined receptors, and it is possible to titrate the respective 
stimulus. To establish our experimental system we stimulated NKL cells by 
crosslinking of NKG2D and visualized Vav1 phosphorylation by western blotting with 
specific antibodies against Vav1 phosphorylated at tyrosine 160 and total Vav1. By 
pretreating the cells with chemical inhibitors we blocked specific signaling steps 
during NK cell activation (Fig. 5). The inhibitors used were Piceatannol that competes 
with substrates of Syk, PP1 that blocks SFKs (especially Lck and Fyn) by binding in 
the ATP pocket, Wortmannin covalently binding to PI3K, PD-98059 preventing the 
activation of MEK, SB-202190 that blocks p38 MAP kinase by binding in the ATP 
pocket and U-73122, a PLC inhibitor. Only the SFK inhibitor PP1 shows a significant 
effect, the Vav1 phosphorylation in PP1 treated cells is even lower than the 
background phosphorylation in unstimulated cells. In the quantification the effect of 
the unspecific PLC inhibitor U-73122 also looks relevant, but as the inactive control 
U-73343 shows the same reduction of pVav1 this could be due to toxic effects of 
these substances. In this experiment we confirmed the specific phosphorylation of 
Vav1 upon NKG2D triggering by antibody crosslinking, which is only depending on 
the functionality of SFKs. 
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Figure 5: Influence of inhibitors on Vav1 
phosphorylation. NKL cells were 
preincubated for 30 min at 37°C with 
indicated inhibitors (see text for 
explanations) and DMSO as solvent control. 
Cells were incubated with anti-NKG2D and 
stimulated with crosslinking antibody for 
1 min on 37°C and immediately lysed. One 
sample of DMSO treated cells was kept on 
ice as unstimulated control. Vav1 
phosphorylation was determined by western 
blotting with antibodies specific for pVav1 
(Y160) and total Vav1. For the quantification 
films were scanned with a densitometer and 
pVav1 [arbitrary units] was calculated as 
pVav1 density divided by total Vav1 density. 
The result is representative for two 
independent experiments. 
4.1.2. Mathematical model of the receptor proximal signaling network 
To investigate the hypothesis that the signals from activating and inhibitory NK cell 
receptors are integrated at the level of Vav1 phosphorylation (Fig. 6b), we 
constructed a mathematical model describing this process (Fig. 6a) in cooperation 
with the division of Theoretical Bioinformatics (DKFZ). This model is based on (bio-) 
chemical reaction kinetics, i.e. bimolecular reaction kinetics for associations, 
unimolecular reaction kinetics for dissociations and Michaelis-Menten kinetics for 
enzymatic reactions. To introduce the required spatial heterogeneity into the 
mathematical model two distinct compartments, 'cytoplasm' and 'immunological 
synapse (IS)' were assumed. Receptor-ligand interactions are restricted to the IS. 
The other reactions can occur in the cytoplasm as well as in the IS. In this model the 
activating receptor NKG2D (exemplified by its associated signaling chain DAP10) 
can interact with MICA on the target cell within the IS of the NK cell. Furthermore 
DAP10 as well as Vav1 can be tyrosine-phosphorylated by SFKs. Phosphorylated 
DAP10 can serve as a binding site for Vav1. To simplify the mathematical model we 
excluded the adaptor molecule Grb2 from the system, which is justified for fast 
pDAP10-Grb2 and Grb2-Vav1 binding reactions. Inhibitory receptors (exemplified by 
the CD94/NKG2A complex) can interact with their MHC class I ligand (HLA-E) in the 
IS, resulting in the phosphorylation of NKG2A by SFKs and the recruitment of SHP-1, 
which can also be phosphorylated by SFKs. All phosphorylation events are 
counteracted by the activity of phosphatases (exemplified here by CD45). The 
activating and inhibitory receptor signaling cascades communicate through SHP-1-
mediated dephosphorylation of Vav1. 
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In order to address several important concepts in immune receptor signaling we 
performed ‘ensemble modeling’ (Kuepfer et al, 2007) and included several optional 
reaction modules in our model (Fig. 6c). (a) pVav1-triggered Actin reorganization, 
leading to increased recruitment of activating receptors (DAP10) in the IS (Graham et 
al, 2006). (b) Following the kinetic segregation hypothesis we excluded the 
phosphatase CD45 from the IS (phosphatase segregation) (Davis et al, 2006). In 
module (c) we assumed an association of SFKs with the phosphorylated receptors 
(kinase association) (Cerny et al, 1997). (d) SFKs can mediate intermolecular 
autophosphorylation resulting in enhanced activity (kinase autophosphorylation) 
(Cooper and MacAuley, 1988), (e) which could be counteracted by SHP-1-mediated 
dephosphorylation (Chiang and Sefton, 2001). (f) Finally, we assumed that SHP-1 
may only be active when it is bound to the phosphorylated NKG2A receptor (SHP-1 
association) (Hof et al, 1998). Combination of the core model and all putative 
modules and considering that module (e) requires module (d) generates 48 different 
potential models of the proximal NK cell signal transduction network. 
 
Figure 6: Modeling the proximal NK cell signal transduction network. a: Graphical representation of the 
mathematical core model. Activating receptor and ligands are shown in green, inhibitory receptors and 
ligands are shown in red. Arrows represent interaction and phosphorylation events. Blunt arrows 
represent dephosphorylation events. The immunological synapse is separated from the cytoplasm by 
the dashed line. b: Graphical representation of the basic hypothesis that activating and inhibitory 
receptor signals are integrated at the level of Vav1 phosphorylation. c: Optional modules used to 
expand the core model with additional reactions as described in the text: (a) actin reorganization, (b) 
phosphatase segregation, (c) kinase association, (d) kinase autophosphorylation, (e) SHP-1 mediated 
kinase dephosphorylation, (f) SHP-1 association 
4.1.3. Spatial dimensions of the cells 
As our model is quantitative, based on ordinary differential equations, we needed 
exact values for the spatial dimensions of NK cells. We used the NK cell line NKL 
and primary NK cells that were expanded with IL-2. The volumes of each cellular 
compartment were calculated based on measurements of the cell diameter and 
literature values (see images in McCann et al, 2007; Vanherberghen et al, 2004) for 
the size of the IS and the nucleus (Fig. 7). These volumes were then used to 
calculate the concentrations of proteins in the compartments. 
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Figure 7: Cellular dimensions. The dimensions of the NK cell line NKL (left) and IL-2 expanded 
primary human NK cells (right) used for modeling are indicated. Diameter of cells was determined 
using a Casy cell counter (Innovatis). The volumes of each compartment were calculated from 
microscopic images from the literature based on the measured dimensions of the cells. Vis, volume 
immunological synapse; dshell, diameter of plasma membrane; Vcyt, volume cytoplasm; dis, diameter 
immunological synapse; Vnuc, volume nucleus; dnuc, diameter nucleus; dcell, diameter cell. 
4.1.4. Quantification of surface molecules 
For running simulations with our model we needed to calculate the concentrations of 
the molecules involved. The surface molecules NKG2D, NKG2A and CD45 were 
quantified with a FACS based assay using commercially available calibration beads 
(Qifikit). These beads are a mixed population, each carrying a defined amount of 
mouse Fc epitopes on their surface. After preincubation of the cells with monoclonal 
mouse antibody against the respective molecule, cells and beads were stained with a 
fluorescent-labeled anti-mouse antibody. With the measured mean fluorescence 
intensity (MFI) of the bead populations and cells the total amount of molecules on the 
cell surface was calculated according to the manufacturers instructions. In 
combination with the cellular dimensions (Fig. 7) we could calculate the 
concentrations for these molecules. A representative staining of the beads and NKL 
cells is shown in Fig. 8 and a summary of the results for NKL and primary NK cells in 
table 1.  
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Figure 8: Representative example for the quantification of surface molecules. a: FACS plots of the 
setup and calibration beads (Qifikit). The setup beads are a mixture of empty beads and beads with 
the maximal amount of epitopes to adjust the settings of the cytometer. The calibration beads consist 
of five populations of beads, each with a defined amount of epitopes. b: FACS plots of NKL cells, 
stained with isotype control or NKG2D specific antibody c: With the information about the amount of 
epitopes on the calibration beads provided by the manufacturer and the MFI of the bead populations 
measured with the staining shown in (a) a calibration curve and function were generated to calculate 
the amount of epitopes on the cells.  
 
Table 1: Summary of the quantification of surface molecules. Numbers are representative for 3 
experiments with NKL cells; quantification with primary NK cells has been done with cells from 4 
different donors. DAP10 numbers, needed for the simulation, were taken as four times the measured 
NKG2D numbers to incorporate the stoichiometry of the NKG2D/DAP10 complex. 
 
 NKL IL-2 expanded primary NK cells 
protein MFI molecules/cell  MFI 
range (mean) 
molecules/cell  
range (mean) 
IgG 6 0 2.97-5.61 
(4) 
0 
NKG2D 65 8400 7.39-15.1 
(11) 
2 648-5284 
(3980) 
CD94 390 55000 66-128 
(94) 
8061-16497 
(12787) 
CD45 807 120000 44-96 
(78) 
5100-16753 
(11756) 
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4.1.5. Production of recombinant Vav1 
For the quantification of cytoplasmic proteins we needed a recombinant standard for 
the detection by western blotting. The commercially available recombinant Vav1 was 
not detectable with our preferred antibodies. So we produced a His-tagged N-
terminal part of Vav1 (amino acids 2-462) by amplifying the respective sequence 
using cDNA from primary human NK cells and sub-cloned it into the pRSet B Vector. 
The protein was over-expressed in E. coli BL21-DE3 PLysS and purified under 
denaturing conditions. Purity was assessed by SDS-PAGE and Coomassie staining 
(Fig. 9a) and total protein concentration was determined using the EZQ Protein 
Quantitation Kit (Fig. 9b) according to the manufacturers instructions. Although the 
recombinant Vav1 was only 15 % pure, detection by western blot did not show 
unspecific binding of Vav1 antibodies or control antibodies to contaminating proteins. 
The concentration of Vav1 less contaminations was calculated and used for the 
following quantification of Vav1 in NKL and primary NK cells. 
 
Figure 9: Production of His-tagged N-terminal partial Vav1. a: The purity of the recombinant protein 
was assessed by coomassie staining and densitometric analysis, Vav1 is 15 % of the total protein. b: 
Concentration of total protein was determined with the EZQ Kit in comparison to a customized BSA 
standard. The EZQ assay membrane was scanned with a FLA-2000, measuring linear arbitrary units 
(lau). The purification contains 1300 ng/µl total protein. 
4.1.6. Quantification of intracellular molecules 
Cytoplasmic proteins were quantified by western blotting using the purified His-
tagged N-terminal partial Vav1 and commercially available recombinant proteins 
(GST-tagged full length LCK, GST-tagged full length SHP-1) as standards. As the 
recombinant proteins differed in size from the endogenous proteins a dilution of the 
standard proteins in constant amounts of cell lysates was subjected to SDS-PAGE 
and western blotting. Representative blots for NKL with quantifications are shown in 
Fig. 10 and a summary of the results for NKL and primary NK cells in table 2. 
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Figure 10: Representative example for the quantification of cytoplasmic proteins. a: Vav1, b: SHP-1 
and c: Lck. Blots were analyzed by densitometrical scanning and a standard curve was created for the 
recombinant protein (indicated in the standard curve and next to the blots by diamonds) and compared 
to the signal of the endogenous protein (indicated by circles). The amount of endogenous protein per 
cell was calculated using the following formula: (measured amount of endogenous protein per lane / 
molecular weight of recombinant protein) * (particles per mol / amount of cells loaded per lane). 
Representative experiments are shown. Results of all quantifications are summarized in table 2. 
 
Table 2: Summary of the quantification of cytoplasmic proteins. For NKL the mean of at least 3 
independent experiments and for primary NK cells the range and mean of at least 5 different donors is 
shown. 
 
 NKL IL-2 expanded primary NK cells 
protein molecules/cell  concentration 
[nM] 
molecules/cell  
range (mean) 
concentration [nM] 
range (mean) 
Lck 710000 1300 553000-1256000 
(760000) 
6460-14680 
(8880) 
Vav1 104000 190 79000-359000 
(197000) 
920-4200 
(2300) 
SHP-1 1900000 3470 405000-648000 
(535000) 
4730-7570 
(6250) 
4.2. Comparing simulation results with experimental data 
4.2.1. Initial simulation results 
We now used the protein quantification data and kinetic parameters derived from the 
literature (Mesecke et al, 2009, in revision) and calculated the steady state 
phosphorylation of Vav1 after target cell contact for different activating (MICA) and 
inhibitory ligand (HLA) concentrations. The ligand concentrations used as an input to 
the models refer to the concentrations in the target cell sub-compartment directly in 
contact with the NK cell.  
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As we wanted to display the response depending on activating and inhibitory 
stimulus in one graph, we use a three-dimensional coordinate system. The 
concentrations of the ligands are displayed on the xy-plane, for better visibility the 
MICA concentration on the y-axis is inversed. The 48 different models basically 
generate two different response behaviors: Models containing only the modules actin 
reorganization (a), phosphatase segregation (b), kinase autophosphorylation (d) and 
SHP-1 mediated kinase dephosphorylation (e) generate a 'valley'-behavior. 
Activating and inhibitory ligands alone have hardly any effect on the Vav1 
phosphorylation, whereas both stimuli together decrease the pVav1-concentration 
below unstimulated levels (Fig. 11a). The same behavior but with a sharper response 
appears when we additionally include the SHP-1 association module (f) (Fig. 11b). 
However, the kinase association module (c) changes the behavior: increasing 
amounts of activating ligands result in enhanced Vav1 phosphorylation, whereas 
simultaneous stimulation with inhibitory ligands reduces the level of pVav1, but not to 
the unstimulated level (Fig. 11c). Again, the inclusion of the SHP-1 association 
module (f) dramatically increases the steepness of this response. Addition of 
inhibitory ligand quickly reduces the Vav1 phosphorylation to background level or 
slightly below and creates a large concentration range of inhibitor dominance 
(Fig. 11d). 
 
Figure 11: Initial simulations of the Vav1 
phosphorylation. Calculations were performed 
by Sven Mesecke from the Division of 
Theoretical Bioinformatics (DKFZ). 4 
representative pVav1 simulations generated 
with the 48 different models are shown. The 
concentration of the NKG2A ligand HLA is 
displayed on the x-axis, the NKG2D ligand 
MICA on the y-axis (inversed) and the pVav1 
concentration is plotted on the z-axis. The 
additional modules added to the core model for 
the simulations shown are indicated above the 
plots and refer to the numbering in figure 6c. 
4.2.2. Confirming activation of NK cells after receptor crosslinking by confocal 
microscopy 
To test the dynamics of Vav1 phosphorylation experimentally, it was necessary to 
titrate the stimulus directed against activating and inhibitory receptors. As there are 
no target cells available that express various amounts of ligands for activating and 
inhibitory receptors and combinations of both we used antibodies to stimulate the 
cells. As observed by confocal microscopy crosslinking leads to capping of the 
receptors on one patch of the cell (Fig. 12). NKL cells were coated with primary 
antibodies directed against activating receptor NKG2D or the inhibitory receptor 
complex CD94/NKG2A followed by crosslinking with secondary antibody. New 
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polymerized actin was stained using phalloidin and showed reorganization of actin 
filaments directed to the site of capping. After 3 and 10 min many cells showed 
relocalization of receptor and actin (representative cells indicated with white arrows), 
but the response to the stimulus was very heterogeneous. This observation confirms, 
that upon receptor crosslinking the NK cells react in a spatially directed manner, like 
upon encounter with a target cell. 
 
Figure 12: Confocal microscopy of NKL stimulated by receptor crosslinking. NKL cells were first 
incubated with antibodies against the inhibitory receptor CD94 or the activating receptor NKG2D. Then 
cells were incubated with Cy3 labeled goat-anti-mouse antibody on ice or for the indicated times on 
37°C to crosslink the receptors. After stimulation cells were immediately fixed, permeabilized and 
stained for actin with Alexa488 labeled phalloidin. Images show the respective receptor and overlays 
with the phalloidin staining of single sections acquired by confocal microscopy and are representative 
of three independent experiments. White arrows point to representative cells that show capping of the 
receptors colocalized with rearranged actin. 
4.2.3. Vav1 phosphorylation shows a 2D-sigmoidal response in NKL 
To compare the modeling results to the Vav1 phosphorylation in NK cells, we used 
NKL and triggered the activating receptor NKG2D and/or the inhibitory receptor 
complex CD94/NKG2A with different concentrations of antibodies followed by 
crosslinking for 5 min. Vav1 phosphorylation was then determined by quantitative 
western blotting (Fig. 13b). Increased engagement of NKG2D triggered strong 
RESULTS 
 
40 
switch-like induction of Vav1 phosphorylation, which was very effectively 
counteracted by co-engaging NKG2A. Interestingly, further increasing NKG2D 
engagement only marginally affected the inhibitory effect of NKG2A. This behavior of 
Vav1 phosphorylation most closely resembled the simulation results obtained with 
the model including the kinase association module (c) and SHP-1 association (f) 
shown in Fig. 13a. The experimental results did not show the same steepness of the 
inhibitory effect as the simulation results. However, this could be explained by the 
western blot method used for the determination of Vav1 phosphorylation, which 
integrates the phosphorylation levels of 100 000 cells. Slight differences in the 
turning point of Vav1 phosphorylation between individual cells can therefore result in 
a more blurry response compared to the single cell simulation results. With the 
reagents available to date it was not possible to measure the Vav1 phosphorylation 
on a single cell level by FACS analysis. 
 
Figure 13: Comparing the experimentally observed Vav1 phosphorylation with the modeling results. 
a: Simulation of pVav1 with the model including kinase association and SHP-1 association (--c--f). 
b: Experimental determined Vav1 phosphorylation after stimulation with various amounts of anti-
NKG2A and anti-NKG2D and crosslinking antibody for 5 min at 37°C. The Vav1 western blots were 
quantified like in Fig. 5 and are displayed in a three-dimensional coordinate system. The result is 
representative for three independent experiments. Module (c) in the simulation was essential to create 
the dose-response profile matching the experimental observation, module (f) created the steepness 
and the strong inhibitor dominance. 
4.2.4. Vav1 phosphorylation shows a sigmoidal response in primary NK cells 
To confirm the physiological relevance of the pVav1 response that we observed in 
the NKL cell line we wanted to reproduce these findings with primary NK cells. As we 
need for our experiments large amounts of an NK cell population with homogenous 
expression of one inhibitory receptor, IL-2-expanded primary human NK cells were 
analyzed by FACS for the expression of NKG2D (Fig. 14a) and inhibitory receptors. 
The majority of NK cells from this donor expressed the inhibitory receptor KIR2DL2/3 
(Fig. 14b). We stimulated the cells with various amounts of antibodies against 
NKG2D and KIR2DL2/3 and analyzed the Vav1 phosphorylation. After NKG2D 
crosslinking alone we observed a steep hyperbolic dose-response of pVav1 
(Fig. 14c). When we used a constant amount of anti-NKG2D and titrated the anti-
KIR2DL2/3 antibody Vav1 phosphorylation was efficiently reduced almost to 
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background levels (Fig. 14d). The dominance of the inhibitory signal was even more 
pronounced than in NKL cells. 
 
Figure 14: pVav1 response in primary NK cells. FACS staining showing the expression of a: NKG2D 
and b: the inhibitory receptor KIR2DL2/3. c: NK cells were stimulated with the indicated amounts of an 
anti-NKG2D antibody followed by crosslinking with goat-anti-mouse antibody for 5 min at 37°C. Cells 
were then lysed and pVav1 was determined by western blotting. d: NK cells were stimulated with 
1000 ng/ml anti-NKG2D plus the indicated amounts of an anti-KIR2DL2/3 antibody followed by 
crosslinking and analyzed for pVav1. Vav1 phosphorylation was quantified like in Fig. 5. 
4.2.5. Confirming the activation of NK cells with antibody coated beads by 
confocal microscopy 
Crosslinking of receptors is one method to stimulate NK cell receptors in a titratable 
way. But the application of the crosslinking antibody that pulls receptors together 
from the outside of the cell could lead to artifacts. To stimulate the cells in a more 
physiological way we also wanted to use antibody coated beads. We first checked for 
saturating antibody load of the beads by FACS staining (data not shown) and mixed 
beads that were saturated with antibody with NKL. In a first experiment we confirmed 
by confocal microscopy that cells formed conjugates with these beads (Fig. 15). Cells 
were stained with phalloidin to visualize actin reorganization and with Choleratoxin 
(CTX) subunit B for lipid rafts. With beads that were not antibody coated or incubated 
with control antibodies (Isotype control, CD56) we observed some background 
activation of the NK cells. But this activation was not directed towards the control 
beads (indicated by blue arrows). Only with anti-CD94 and anti-NKG2D we detected 
actin polymerization that was in most cases directed toward the beads (white 
arrows). With anti-NKG2D we additionally observed, that actin and the CTX stained 
membrane wrap around the beads.  
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Figure 15: Analysis of NKL-bead conjugates by confocal microscopy. NKL cells were incubated with or 
without beads on Poly-L-Lysine (PLL) coated coverslips for 30 min. Then cells were stained with 
Alexa488 labeled CTX, fixed, permeabilized and stained with Tritc labeled phalloidin. Images show 
single sections acquired by confocal microscopy. To visualize the position of the beads, DIC pictures 
were acquired, and in inverse color overlaid with the fluorescent images. Blue arrows point to beads 
attached to cells without, white arrows with, directed actin polymerization. 
4.2.6. Vav1 and ERK phosphorylation induced by antibody coated beads 
After we confirmed binding of antibody-coated beads to NK cells and observed 
activation by microscopy we used these beads to stimulate NK cells. We first tested 
the optimal stimulation time with the beads. In contrast to antibody crosslinking the 
phosphorylation of Vav1 occurred much slower with an initial lag phase of 4-5 min 
and reached the maximum after 10-15 min (data not shown). A possible explanation 
for the slower kinetic is that the antibodies on the beads are immobile, and diffusion 
can only occur on the NK cell membrane. Starting with the saturating concentration 
of anti-NKG2D antibody, as determined by FACS, we coated the beads with 
decreasing amounts of antibody and mixed them at a 1:1 ratio with the NK cells. With 
this stimulation method we were also able to detect a concentration dependent steep 
increase of phosphorylated Vav1 (Fig. 16a,b). The MAPK cascade is another 
signaling event necessary for the cytotoxic response of NK cells, and is induced after 
activating receptor stimulation. Therefore we also checked for ERK1/2 activation with 
antibodies specific for double phosphorylated and total ERK1/2 (Fig. 16c,d). Using 
coated beads we observed a dose-response similar to the response induced by 
receptor crosslinking.  
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Figure 16: Phosphorylation of Vav1 and ERK1/2 after stimulation with anti-NKG2D coated beads. NKL 
cells were stimulated for 20 min on 37°C at a 1:1 ratio with beads coated with various amounts of anti-
NKG2D. Cells were then lysed and analyzed for b: Vav1 and d: ERK1/2 phosphorylation by western 
blotting. a,c: Blots were quantified as described in Fig. 5, both proteins show a very steep antibody-
concentration dependent increase in phosphorylation. The result is representative for two independent 
experiments. 
4.2.7. Testing the kinetic parameters used in our model 
We quantified the concentrations of the molecules involved in our model, but we also 
needed kinetic parameters for all occurring reactions to run the simulations. So our 
cooperation partner extracted the necessary values from the literature. These 
parameters varied in some cases over magnitudes and were measured in different, 
sometimes quite artificial systems. Using the literature derived parameters for our 
simulations, the kinase association module (c) was essential to produce a physiologic 
response, and the SHP-1 association module (f) produced the required steepness 
(see Fig. 11c,d). Two different methods can be applied to assess kinetic parameters 
in mathematical models. One possibility is to perform a parameter fit. This method 
aims at fitting the kinetic parameters to match the simulation to the experimental 
data. The result of this parameter fit reassured, that the kinase association is 
essential for our model to create the physiologic response and not only depending on 
kinetic parameters. All models lacking the kinase association failed and showed a 
'valley' behavior (similar to Fig. 11a,b). The steepness of the onset of the inhibitory 
signal was not only dependent on SHP-1 association with the fitted parameters.  
The second possibility to test the kinetic parameters is to perform a parameter scan. 
The kinetic parameters were randomly varied over 4 log scales to generate 5000 sets 
of random parameters. For each of these parameter sets the Vav1 phosphorylation 
was simulated with the 48 models. The resulting simulation profiles were then 
RESULTS 
 
44 
classified automatically to 9 different possible shapes; only one of these shapes 
represents the experimentally observed response. Also with this method we could 
show that the kinase association module (c) is essential to create a physiological 
response. With these methods we assured, that module (c) is a critical reaction in our 
simulation. Our model is very stable and does not depend on a small range of kinetic 
parameters. 
4.2.8. Association of NKG2D with SFKs 
Our model suggests that association of SFKs with the activated receptor is absolutely 
essential for the observed Vav1 response. Most of our experiments were performed 
by stimulating the NKG2D receptor, direct downstream mechanisms for this receptor 
are only partially described. So we decided to check for association of this receptor 
with SFKs in a Co-immunoprecipitation approach (Fig. 17). As harsh detergents 
disrupt weak protein interactions we lysed the cells in a Brij-58 containing buffer, 
which is a very mild detergent. The receptor gets recruited to detergent resistant 
membrane domains after stimulation, so the majority of the receptor gets lost during 
clarification of the lysates. To avoid this we established an immunoprecipitation 
protocol from whole cell lysates using magnetic beads. Nevertheless we also noted a 
slight decrease of recovered receptor in stimulated samples; probably the receptor is 
less accessible to precipitation after stimulation. The SFKs Fyn and Lck weakly 
associated with NKG2D in lysates from unstimulated cells, but upon crosslinking of 
NKG2D we detected high amounts of Fyn and Lck. Additionally Vav1 could be co-
precipitated, and this receptor bound Vav1 was strongly phosphorylated. Here we 
were able to show, that upon receptor crosslinking we find an increase in associated 
SFKs, which creates a high local concentration of kinases at the stimulated 
receptors. 
 
Figure 17: Immunoprecipitation of NKG2D with 
associating proteins. NKL cells were first 
incubated with anti-NKG2D. One aliquot was 
incubated for 3 min at 37°C without crosslinking 
antibody, one with crosslinker on ice and 
another with crosslinker at 37°C. Cells were 
then lysed using the mild detergent Brij-58 and 
NKG2D was precipitated from whole cell 
lysates (WCL) using Protein G coated magnetic 
beads. Proteins eluted from the beads and an 
aliquot of the WCL were analyzed. We were 
able to detect the adapter DAP10 in every 
sample. The amount of SFKs Fyn and Lck that 
were co-precipitated was strongly increased 
after receptor crosslinking. Detection of 
phosphorylated Vav1 confirmed enrichment at 
the site of stimulation and the activation of the 
cells. The result is representative for three 
independent experiments. 
 
RESULTS 
 
45 
4.2.9. SHP activity: Phosphorylation, association or location? 
In previous studies it already has been shown that SHP-1 can associate with 
phosphorylated ITIMs of inhibitory receptors, which we included in our model as 
module (f). But SHP-1 also could be phosphorylated itself, resulting in increased 
activity of the phosphatase. In order to distinguish between these two possible 
regulation mechanisms, we immunoprecipitated SHP-1 and applied a commercially 
available activity assay. This assay detects free phosphate after cleavage of a SHP 
specific substrate. We detected specific SHP-1 activity, as we could block phosphate 
release with the phosphatase inhibitor pervanadate to the same background level we 
found in a preclear IP that did not contain any SHP-1. The SHP-1 activity did not 
change from the level of unstimulated cells when we crosslinked the inhibitory 
receptor NKG2A alone or in combination with NKG2D (Fig. 18a). By western blotting 
we were able to detect approximately equal levels of SHP-1 in every sample 
(Fig. 18b), but we could not detect any phosphorylation by using the phospho-
tyrosine specific antibody 4G10 (data not shown). This supports the hypothesis, that 
phosphorylation of SHP-1 is not required, but that the association of SHP-1 with the 
receptor is essential for the inhibitory function. 
 
Figure 18: Measuring SHP-1 activity. SHP-1 
was first precipitated from lysates of differently 
stimulated NKL cells, as a negative control 
Protein G agarose beads without antibody were 
used. a: These beads were incubated with a 
phosphorylated SHP specific substrate, to block 
Phosphatase activity pervanadate was added to 
one sample during the substrate reaction. As 
readout free phosphate was measured and 
compared to a standard. b: Precipitated SHP-1 
was further analysed by western blotting which 
confirmed equal amounts of SHP-1 in the 
samples. Phosphorylation of SHP-1 was not 
detected with the 4G10 phosphotyrosine 
specific antibody (data not shown). The results 
are representative for at least three 
independent experiments. 
4.2.10. Quantification of Vav1 and SFK phosphorylation levels 
Our quantitative model also gives us information about the absolute concentration of 
phosphorylated signaling molecules; we wanted to confirm this data experimentally. 
As we could not obtain phosphorylated recombinant standard proteins to quantify the 
amount directly, we chose a semiquantitative method. By treating cells with the 
phosphatase inhibitor pervanadate we created a lysate with maximum 
phosphorylated proteins (100 %) and by incubating cells with the SFK inhibitor PP1 
we obtained lysate with the minimal phosphorylation (0 %). The maximum 
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phosphorylation lysate was then diluted in the minimal phosphorylation lysate and 
used to create a standard. This standard and lysates of cells stimulated via receptor 
crosslinking were then analyzed by quantitative western blotting (Fig. 19c,d). We 
created a standard curve and compared it with the phosphorylation levels of cells 
stimulated via NKG2D and NKG2A (Fig. 19a,b). About 11 % of Vav1 was 
phosphorylated after NKG2D crosslinking whereas after NKG2A stimulation Vav1 
phosphorylation was not higher than in the medium control. No significant SFK 
phosphorylation could be detected after receptor crosslinking. Therefore we can 
exclude, that the kinase autophosphorylation module (d) plays a role in our 
experimental system. A maximal Vav1 phosphorylation of 11 % corresponds to a 
concentration of 20 nM pVav1. The simulations with literature derived kinetic 
parameters predicted a lower phosphorylation level, but after fitting of the parameters 
our model including (c) and (f) could produce 16 nM of maximal Vav1 
phosphorylation.  
 
Figure 19: Semiquantitative analysis of Vav1 and SFK phosphorylation. The lysate of pervanadate 
stimulated cells was diluted in lysate of PP1 pretreated cells to create a standard and compared to 
lysates from cells activated via receptor crosslinking. Standard curves for a: pVav1 and b: SFK 
phosphorylation (detected with anti-pSrc) are shown (filled circles) with the respective crosslinked 
samples (open symbols). The blots quantified are shown in c and d. e: The results of 3 independent 
experiments are summarized as mean with STD. 
4.2.11. Kinetic of Vav1 phosphorylation after NKG2D stimulation 
To further validate the physiologic response of the core model containing the kinase 
association module (c), we calculated the kinetic change in Vav1 phosphorylation 
upon NKG2D triggering. The model predicted a rapid increase in Vav1 
phosphorylation which reached a plateau about 200 seconds after NKG2D receptor 
engagement (Fig. 20a). While lowering the initial MICA concentration reduced the 
amplitude of the Vav1 phosphorylation, the time needed to reach the phosphorylation 
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plateau remained unchanged. To validate these results experimentally we triggered 
the NKG2D receptor on NK cells and determined the kinetics of Vav1 
phosphorylation by western blotting (Fig. 20b). In agreement with the simulation 
results we observed a rapid increase of Vav1 phosphorylation, which reached its 
maximum at about 90 seconds after receptor engagement. Reduced engagement of 
NKG2D with suboptimal antibody concentrations resulted in lower Vav1 
phosphorylation with unchanged kinetics, confirming the predictions of the model. 
However, in contrast to the simulation results, we observed a reduction of Vav1 
phosphorylation between 5 and 10 min after receptor engagement. This suggests the 
presence of negative regulatory signaling pathways to terminate the signal, which are 
presently not incorporated in our model.  
 
Figure 20: Kinetic of the Vav1 phosphorylation depending on differential engagement of the activating 
receptor NKG2D. a: The indicated concentrations of the NKG2D ligand MICA were used in the model 
to calculate the kinetic change in Vav1 phosphorylation. b: Vav1 phosphorylation in NKL cells was 
then determined experimentally by crosslinking the NKG2D receptor using the indicated 
concentrations of anti-NKG2D antibody. One representative experiment out of four is shown.  
4.2.12. Ca2+ flux after stimulation of activating and inhibitory receptors 
Additionally to Vav1 phosphorylation we studied Ca2+ flux as a very fast responding, 
receptor proximal signaling event. Our hypothesis is that the activating and inhibitory 
signals get integrated on the level of Vav1 first and pass this signal on.  
We labeled NKL with the Ca2+ sensitive dye Fluo4, which increases its fluorescence 
after Ca2+ influx. By using a plate reader we could quantify multiple samples with 
different stimulation conditions at once and also include kinetic data. Cells were first 
incubated with various concentrations of antibodies against the activating receptor 
2B4 and the inhibitory receptor complex NKG2A/CD94. The baseline of Fluo4 
fluorescence was recorded, then crosslinking antibody was added to all wells at the 
same time and the kinetic Ca2+ response was recorded until a plateau was reached. 
An example for one concentration of anti-2B4 and various anti-CD94 concentrations 
is shown in Fig. 21. Control antibody did not induce Ca2+ flux, but anti-2B4 produces 
a sharp increase in fluorescence. This signal can be inhibited by anti-CD94 in a dose 
dependent way. As the data obtained with the plate reader measurement is very 
noisy and we sometimes observed already different basal fluorescence levels before 
crosslinking, we decided to quantify the Ca2+ flux as area under the curve from the 
moment of crosslinker addition until the plateau was reached (about 7 min). This 
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quantification has the additional advantage, that we can compare all combinations of 
stimulation in one matrix (Fig. 22). In this experiment we observed, that similar to 
Vav1 phosphorylation the Ca2+ signal can be inhibited in a dose dependent way and 
the inhibitory signal is dominant over the signal from activating receptors.  
 
Figure 21: Kinetic of Ca2+ flux after stimulation of activating and inhibitory receptors. NKL were labeled 
with the Ca2+ sensitive dye Fluo4 and incubated with 2,5 µg/ml of anti-2B4 and various amounts of 
anti-CD94. We first recorded the baseline of Ca2+ flux; upon crosslinker addition (indicated as black 
arrow) we noted a strong increase of Fluo4 intensity in the samples incubated with more anti-2B4 than 
anti-CD94. Samples incubated with equal amounts, more anti-CD94 or control antibody did not show 
this increase. Mean values of triplicate samples are shown, and are representative for three 
independent experiments. 
 
 
Figure 22: Ca2+ signal after various stimulations 
of activating and inhibitory receptors. To display 
the Ca2+ signal upon various activating and 
inhibitory signals we recorded the kinetic from 
the moment of crosslinker addition until the 
plateau was reached (15 time points, about 
7 min) and displayed the result as area under 
the curve. With this method we can display all 
combinations of activating and inhibitory 
stimulus in one matrix. Ca2+ signal induced by 
2B4 stimulation can be effectively blocked by 
CD94 triggering. 
4.3. Challenging our model 
4.3.1. NKG2D clustering is not affected by MEK and SFK inhibitors 
So far we confirmed that our model is able to produce physiological endpoint and 
kinetic simulations for the phosphorylation of Vav1. To further test the reliability of our 
model we perturbed the signaling cascade by the use of chemical inhibitors. We first 
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tested the influence of SFK and MEK on the response of NKL cells after receptor 
crosslinking (Fig. 23). The cells were pretreated for 30 min on 37°C with the 
respective inhibitors or DMSO as solvent control. We preincubated the cells with anti-
NKG2D antibody and crosslinked the receptor for 10 min or incubated a control 
sample on ice. Cells were immediately fixed, permeabilized and stained for actin. 
After incubation on ice the NKG2D receptor and actin were distributed 
homogeneously around the cell, but after incubation on 37°C most of the cells 
showed capping of the receptor on one site of the cell, which colocalized with 
polymerized actin. Treatment with inhibitors did not influence the overall morphology 
of the cells. Receptor capping was not reduced, suggesting that this process is 
upstream of SFK and MEK activity. 
 
Figure 23: Effect of MEK and SFK inhibition on 
receptor capping. NKL were pretreated for 
30 min on 37°C with the MEK inhibitor PD-
98059, the SFK inhibitor PP1 or DMSO as 
solvent control. We incubated the cells with 
anti-NKG2D antibody and afterwards incubated 
with a Cy3 labeled crosslinking antibody for 
10 min on ice or at 37°C. After fixation cells 
were permeabilized and stained with Alexa488 
labeled phalloidin. Images show overlays of 
single sections acquired by confocal 
microscopy and are representative of two 
independent experiments. 
4.3.2. Effect of reduced SFK activity on the kinetic of Vav1 phosphorylation 
As kinase association (c) was identified as crucial step for the phosphorylation of 
Vav1, we challenged our model by SFK inhibition. We reduced the activity of SFKs in 
our model and experimentally by PP1 treatment and measured the kinetic of Vav1 
phosphorylation. Simulation of the core model containing module (c) with decreased 
SFK activity predicted a reduced steepness of the Vav1 phosphorylation dynamics 
and a decrease in the final pVav1 concentration (Fig. 24a). To test these predictions 
experimentally we measured Vav1 phosphorylation in response to engaging the 
NKG2D receptor in the presence of different PP1 concentrations (Fig. 24b). Without 
inhibitor we observed a rapid increase in Vav1 phosphorylation reaching its plateau 
at about 90 seconds after NKG2D engagement. The presence of increasing PP1 
concentrations affected the kinetics, slope and amplitude of Vav1 phosphorylation, 
essentially confirming our simulation results. As we confirmed before that treatment 
with PP1 did not affect clustering of the receptor we concluded, that this effect was 
really due to inhibition of SFK activity. 
RESULTS 
 
50 
 
Figure 24: Kinetic changes in Vav1 phosphorylation depending on SFK activity. a: The activity of SFKs 
was reduced to 10 % or 1 % of the original values and the kinetic changes in Vav1 phosphorylation 
were calculated after triggering with 200 µM MICA. b: Vav1 phosphorylation was then determined 
experimentally by crosslinking NKG2D on NKL pretreated for 30 min with the indicated concentrations 
of PP1 or DMSO as control. Representative data of three independent experiments are shown. 
4.3.3. Cytotoxic activity corresponds to Vav1 phosphorylation 
If Vav1 phosphorylation is the decision making point for NK cell activation, the 
decision made at this level is then transmitted to downstream signaling pathways 
resulting in the cytotoxic activity of NK cells. This hypothesis would therefore predict 
that the profile of Vav1 phosphorylation upon engagement of activating and inhibitory 
receptors is paralleled by NK cell cytotoxicity. To test this, we determined the 
cytotoxic activity of NK cells upon differential triggering of activating and inhibitory 
receptors in a redirected lysis assay using Fc receptor positive target cells. 
Increasing the level of NKG2D engagement resulted in a rapid increase of target cell 
lysis by NKL cells quickly reaching a plateau (Fig. 25a). Co-engagement of the 
inhibitory CD94/NKG2A receptor very effectively blocked target cell lysis even at very 
low concentrations and created a large concentration range where the inhibitory 
signal dominated the response. A similar dose-response was observed when using 
an NK cell clone expanded from primary human NK cells (Fig. 25b). The profile of 
cytotoxicity nicely paralleled the Vav1 phosphorylation levels predicted by our 
mathematical model including all optional modules (Fig. 25c), supporting the 
hypothesis that pVav1 levels establish a key checkpoint for NK cell cytotoxic activity.  
 
Figure 25: The cytotoxic activity of NK cells correlates with Vav1 phosphorylation. a: NKL cells and b: 
a primary human NK cell clone expressing the inhibitory CD94/NKG2A receptor were used in a 4h 
redirected 51Cr release assay. The NKG2D and the CD94 receptor were triggered with the indicated 
concentrations of antibodies and the resulting lysis of the target cells is indicated. Representative of a: 
five and b: two independent experiments. c: The calculated pVav1 response upon differentially 
triggering of activating and inhibitory receptors using the complete mathematical model. 
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4.3.4. Effect of reduced SFK activity on pVav1 response and cytotoxicity 
Additionally to changes in the kinetic of the pVav1 response (shown in Fig. 24), the 
SFK inhibitor PP1 also reduced the amplitude of the signal. Our model produced 
physiological endpoint simulations for the phosphorylation of Vav1 (Fig. 13), and the 
dose-response of cytotoxicity followed the Vav1 phosphorylation. If the decision 
about NK cell activation is made on the level of Vav1 phosphorylation, disturbing the 
NK cell activation with PP1 should have the same effect on cytotoxicity as on pVav1. 
Therefore we checked Vav1 phosphorylation after 5 min of differential engagement of 
NKG2D and NKG2A/CD94 with and without partial SFK inhibition (Fig. 26c&d). Also 
in this experiment we noted the decrease in maximal Vav1 phosphorylation, while the 
overall shape of the response was preserved. This is consistent with the predictions 
of our model (Fig. 26a&b). To examine the effect of PP1 on cytotoxicity we performed 
redirected a lysis assay like in Fig. 25a with or without PP1. Reducing the SFK 
activity only reduced the maximum cytotoxicity, but the profile of the response 
remained unchanged, further validating our hypothesis. 
 
Figure 26: Comparison between predicted and experimentally observed pVav1 and cytotoxic response 
after reducing SFK activity. Using the core model including module (c) and (f) the phosphorylation of 
Vav1 for different activating and inhibitory ligand concentrations was simulated with a: full or b: 10 % 
SFK activity. The human NK cell line NKL was pretreated d: with 5 µM or c: without PP1 for 30 min at 
37°C and then incubated with the indicated concentrations of antibodies against the activating 
receptor NKG2D and the inhibitory receptor NKG2A. After crosslinking with secondary antibodies cells 
were incubated at 37°C for 5 min. Vav-1 phosphorylation was determined by quantitative western 
blotting. NKL f: with 5 µM or e: without PP1 were also used in a redirected lysis assay to measure their 
cytotoxic activity. 
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5. Discussion 
5.1. How are activating and inhibitory signals integrated by NK cells 
NK cells receive signals via many activating and inhibitory receptors, that cause a 
gradual signal input. The cytotoxic response of an NK cell towards a target cell is a 
yes or no decision. NK cells have to integrate the multitude of incoming signals to 
decide if they kill or do not kill the target cell. But how do the cells calculate this? The 
easiest explanation is, that activating and inhibitory signals converge at one point in 
the signaling cascades initiated by the different receptors. Inhibitory receptors 
transmit the signal via phosphatases recruited to ITIMs, but different activating 
receptors initiate different activation cascades and all can be blocked by inhibitory 
signals. Promising candidates to integrate the signal are the GEFs belonging to the 
Vav family. Vav1 is a known direct target of the phosphatase SHP-1 and is part of the 
signals induced by the activating receptors NKG2D and 2B4 studied here.  
We therefore propose a model that could describe how activating and inhibitory 
signals get integrated directly receptor proximal on the level of Vav1 phosphorylation. 
Mathematical analysis of the possible reactions should reveal if this simple system 
already provides the possibilities to integrate the signals and to produce a 
physiological response. Additionally, the gradual activating and inhibitory signal input 
has to be transformed to permit the cell to come to a reliable killing decision. 
The Vav1 phosphorylation upon differential stimulation showed a switch-like behavior 
towards activation and inhibition. Our simplified model was able to simulate a 
physiological dose-response of pVav1, but including the association of the kinase 
with the receptors (c) was absolutely essential. We confirmed this interaction in our 
system experimentally. With a regular co-immunoprecipitation protocol, we noted 
high loss in the amount of NKG2D recovered after stimulation, compared to 
unstimulated controls. We observed that the receptor is found in the nuclear fraction 
after clarification of the lysates (data not shown). It has been demonstrated before, 
that NKG2D and other activating NK cell receptors get recruited to GM-1 rich 
membrane domains (lipid rafts) after stimulation. SFKs are localized constitutively in 
lipid rafts through posttranslational addition of a lipid anchor (Shenoy-Scaria et al, 
1993). In conjugates with target cells expressing NKG2D ligands, the NKG2D 
receptor and GM-1 rich membrane domains cluster at the contact area. Also after 
stimulation by crosslinking NKG2D is recruited to lipid rafts and clustering of the rafts 
is induced (Endt et al, 2007). If we stimulated the cells with anti-NKG2D coated 
beads, these beads were often completely surrounded by GM-1 rich membrane, 
which we did not observe with control or inhibitory antibody coated beads. The lipid 
rafts are insoluble in cold non-ionic detergents, due to their molecular composition. 
Clusters of these lipid rafts are lost for immunoprecipitation performing a standard 
protocol through clarification of the lysates. Therefore we established an 
immunoprecipitation protocol from non-clarified whole cell lysates, in which lipid rafts 
are still present and intact. Although we optimized the protocol and kept antibody 
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concentrations constant in all samples, we recovered less receptor after crosslinking 
on ice or 37°C. Probably the antigen is less accessible after crosslinking or masked 
due to the clustering. Nevertheless the amount of the SFKs Lck and Fyn in the 
precipitates increased in stimulated samples. As we lysed the cells under conditions 
that did not disrupt lipid rafts, this increase in SFKs could be due to direct protein 
interaction with the stimulated receptor or to localization of receptor and kinases in 
close proximity linked through the membrane domains. The importance of lipid rafts 
as a platform for the signaling of activating receptors has been described before. A 
disruption of these membrane domains by depletion of cholesterol from the 
membrane leads to a complete loss of NK cell function (Watzl et al, 2003). Especially 
for Lck we noted a high background association with NKG2D after crosslinking on 
ice. Probably the induction of the association is so sensitive, that it can occur under 
these experimental conditions. Activation of the cells occurs specific upon NKG2D 
crosslinking on 37°C as observed by Vav1 phosphorylation, additionally we observed 
recruitment of Vav1 to the stimulated receptor. Vav1 precipitated with the stimulated 
receptor was highly phosphorylated. This suggests that through the association of 
kinases and Vav1 with the stimulated receptor phosphorylation of Vav1 is facilitated.  
Our simulations and experimental results suggest, that the high local concentration of 
kinases and their substrates is a key mechanism to induce NK cell activation. 
Semiquantitative analysis revealed, that about 11 % (20 nM) of Vav1 that could be 
phosphorylated with pervanadate are phosphorylated upon triggering of NKG2D. We 
could not test how efficient the pervanadate treatment phosphorylated the proteins, 
but it is unlikely that all Vav1 molecules present in the cell were phosphorylated. 
Therefore measuring the percentage of pVav1 with this method can lead to an 
overestimation of the total amount of pVav1. Our simulations produced a much lower 
phosphorylation level of pVav1 with literature derived kinetic parameters. In the 
parameter fit we reached a pVav1 level of 16 nM, when we included the kinase- and 
SHP 1 association modules (c) and (f). Assuming that the experimentally determined 
20 nM pVav1 are the upper limit of the possible phosphorylation level, the simulation 
results would be in a realistic range. We recovered a high amount of phosphorylated 
Vav1 in the precipitates of stimulated NKG2D compared to total Vav1. Therefore we 
hypothesize that the magnitude of Vav1 at the activation site gets phosphorylated 
due to the high local concentration of SFKs, whereas the phosphorylation level in the 
rest of the cell is lower. This spatially restricted phosphorylation could contribute to a 
directed activation of the NK cells towards the susceptible target cell. 
The second important result from our simulations is, that the steep decrease of 
pVav1 upon stimulation of inhibitory receptors was depending on the association of 
the phosphatase SHP-1 with the inhibitory receptors (f). In the simulations without 
this module, the activity of SHP-1 is increased by phosphorylation, whereas in 
simulations with (f) the interaction with inhibitory receptors activates the phosphatase 
and phosphorylation does not contribute to regulate the activity. Induced association 
of SHP-1 with ITIM bearing receptors and phosphorylation of SHP-1 has been 
demonstrated before (Hof et al, 1998; Lu et al, 2001), both resulting in increased 
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activity of the phosphatase. But which mechanism is responsible for the observed 
response in our experimental system? We applied an assay that could detect specific 
SHP-1 activity in NK cells. This activity was completely blocked when the 
phosphatase inhibitor pervanadate was added to the substrate reaction. But 
stimulation of activating and/or inhibitory receptors did not change the observed 
activity of SHP-1 significantly. We could not detect phosphorylation of SHP-1 in 
precipitates from the SHP-1 activity assay nor in conventional immunoprecipitates 
(data not shown) after receptor stimulation. This suggests that in our experimental 
system, phosphorylation of SHP-1 is not responsible for the observed dose-
response, which is in agreement with the simulation results. If phosphorylation is not 
involved in regulating SHP-1 activity, then we would expect, that the interaction with 
the ITIMs of inhibitory receptors increases the activity. But under experimental 
conditions that induced this association, we could not detect changes in SHP-1 
activity compared to unstimulated controls. One explanation why the measured 
activity of SHP-1 is unaffected by receptor stimulation is that the assay used is not 
suitable to detect changes in activity due to conformational changes. Cell lysis and 
precipitation of SHP-1 could disrupt either the association of receptor and 
phosphatase or disturb the conformation of the complex necessary for SHP-1 
activation. The other possible explanation is, that the activity of SHP-1 does not 
change significantly upon receptor stimulation in our system, but association of 
SHP-1 with the receptor and the resulting increased local concentration at the IS is 
sufficient for the observed effect. Further studies testing the SHP-1 activity in intact 
cells will be necessary to answer the real contribution of the association to the 
receptor on the activity of the phosphatase. To distinguish the two functional 
concepts a membrane-targeted mutant of SHP-1 could help to reveal if the high local 
concentration at the membrane is of importance and a fluorescence resonance 
energy transfer (FRET)-probe could visualize conformational changes of the 
phosphatase. 
The other optional modules of our model were not essential to create a physiological 
response. While phosphatase exclusion (b) has been suggested for the initiation of 
TCR signaling, it is dispensable in our model. This is consistent with the fact that 
CD45 is not necessary for NK cell cytotoxicity (Hesslein et al, 2006; Huntington et al, 
2005). The kinase autophosphorylation module (d) assumes, that the background 
activity of SFKs is enhanced after phosphorylation of an activating tyrosine. In our 
model this is implemented by increasing the basal SFK activity 5-fold after 
autophosphorylation. This module was dispensable in the simulations using kinetic 
parameters from the literature. But it increased the number of random parameter sets 
in our parameter scan that produced a physiological response. This can be explained 
by the fact that this module helps creating the physiological response with parameter 
sets containing lower basal SFK activity. However, we were not able to detect 
relevant levels of SFKs phosphorylated at the activating tyrosine after receptor 
engagement, a finding that is consistent with the lack of SFK phosphorylation upon T 
cell activation (Paster et al, 2009). These data suggest that either the 
DISCUSSION 
 
55 
autophosphorylation of SFKs is so transient that we could not detect it 
experimentally, or what is more likely; the basal SFK activity without 
autophosphorylation in human NK cells is sufficiently high to induce the observed 
pVav1 response and cytotoxicity. The additional module (e) hypothesizing SFK 
dephosphorylation by SHP-1 was only playing a very minor role in improving the 
simulations. As we exclude the necessity of SFK autophosphorylation, we assume 
that this process is not involved in the signal integration of NK cells. To our surprise, 
the pVav1 triggered actin reorganization, which leads to active recruitment of 
activating receptors to the IS, was also not necessary in our simulations. Blocking the 
actin rearrangement experimentally leads to a complete abrogation of cytotoxicity 
and a reduction of Vav1 phosphorylation. How can this discrepancy be explained? In 
our model without module (a), the clustering of the receptors occurs in a passive 
way. The receptors can move all over the cell, and get trapped at the IS if their ligand 
is present on the target cell. Module (a) leads to an acceleration of receptor 
recruitment to the IS and can also actively retain the receptors in this area. One 
possibility for the discrepancy is, that we assume in our model a motility of the 
receptors and signaling proteins that cannot be achieved in cells without the active 
contribution of the cytoskeleton. In our simulations the cytoplasm and the plasma 
membrane of the cells are homogeneous solutions of molecules, where the diffusion 
speed is constant. Whereas in ‘real’ cells active transport of the proteins might be 
necessary, as the cytoplasm is crowded with organelles and the plasma membrane 
has a complex organization. For a functional IS, not only the activating and/or 
inhibitory receptors are necessary but also adhesion molecules, which we omitted in 
our simulation, as they do not contribute to the killing decision. Integrins like LFA-1 
are crucial for the formation of a stable IS and intimately coupled to regulation of the 
actin cytoskeleton. We would miss effects caused by relocalization and activation of 
adhesion molecules to stabilize the synapse in our simulation. The initial pVav1 
signal probably is actin independent but without the actin dependent maintenance of 
the synapse, the conjugate of NK and target cell falls apart and the signal is 
abrogated. The actin relocalization could be responsible for an increase and an 
acceleration of the Vav1 phosphorylation but also enable the induction of signaling 
cascades downstream of Vav1. 
While our results demonstrate that SFK and SHP-1 association with the respective 
receptors are essential for the signal integration of NK cells, it does not exclude the 
possibility that the remaining optional modules may play a role during the integration 
of positive and negative signals. None of the remaining modules impaired the 
simulation results, when they were included additionally. 
5.2. Experimental factors influencing the mathematical model 
Stimulating cells by antibody crosslinking or with antibodies coated to surfaces is a 
common but controversial method. We chose this approach, as we needed to titrate 
the signal to reveal concentration dependent dynamics. Currently there are no target 
cells available that display the defined various ligand densities on the surface that we 
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require. Different affinities of the various ligands and of antibodies towards the 
receptors could influence the quantitative but not the qualitative response of the cell. 
The receptors do not undergo conformational changes upon ligand binding, but bind 
as rigid bodies (Boyington et al, 2001; McFarland and Strong, 2003). Further 
quantitative comparisons could answer the question which ligand density on a target 
is required to induce the response we observed at a certain antibody concentration. 
After stimulating NK cells with targets, the initiated signals are not well-defined, as 
other ligands like adhesion molecules contribute to the effects. An alternative would 
be the expression of the desired ligands in insect cells, as these cells do not express 
ligands cross-reactive with human NK cell receptors. A titratable and inducible 
expression system for the ligands is currently in development, to avoid the need for 
multiple target cell lines expressing various levels of two different ligands. The 
process of activating receptor clustering at the IS has been shown to be actin 
dependent whereas the clustering of inhibitory receptors in inhibitory synapses is 
thought to be independent of actin polymerization (Long, 2008; Watzl et al, 2003). 
We observed actin relocalization with crosslinking of activating and inhibitory 
receptors, which is contradictory to results with target cells. Surprisingly, PP1 
treatment did not affect capping of the NKG2D receptor after crosslinking. In most of 
the cells showing receptor relocalization we also noted actin enrichment directed to 
the site of receptor capping. The activation of GTPases by pVav1 is inducing actin 
cytoskeleton rearrangement. It is possible that the inhibition of SFKs by PP1 is 
incomplete and the remaining activity is sufficient to induce actin polymerization, 
although we could not detect pVav1. Another explanation would be that crosslinking 
of receptors with secondary antibody clusters the receptors from the outside of the 
cell, and this process is followed by activation independent actin accumulation. As 
conjugate formation and actin rearrangement are only slightly diminished in NK cells 
from mice lacking Vav1, there exist mechanisms completely independent of Vav1 
(Colucci et al, 2001). This mechanism could also be responsible for the clustering in 
our cells stimulated in the presence of PP1. The observed phenomenon of receptor 
and actin relocalization in the absence of pVav1 is similar to the response after 
crosslinking of inhibitory receptors. Despite the actin accumulation, the receptor 
clusters did not induce activation signals as pVav1 and cytotoxicity were completely 
abolished at the PP1 concentration used in these experiments. To avoid receptor 
crosslinking with secondary antibody we stimulated the cells also with antibody-
coated beads. The idea is to stimulate one specific receptor, but on a cell shaped 
and cell sized surface. With this method we wanted to reassure, that the signaling 
events we observed with receptor crosslinking are not caused by applying an 
external force pulling the receptors into a cluster. We noted some background actin 
polymerization with control beads but the actin rearrangement was not directed and 
phosphorylation of Vav1 or ERK was not induced. We speculate that this background 
is just due to mechanic disturbance of the cells by the beads. When we used beads 
coated with antibody against activating or inhibitory receptor the actin polymerization 
was directed in both cases towards the beads, similar to the observation after 
crosslinking of these receptors. Despite of the differences in actin rearrangement 
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after stimulating the cells with soluble antibodies, beads or target cells, the signaling 
events caused by triggering NK cell receptors were comparable between the 
stimulation methods. The kinetic of Vav1 phosphorylation after activation by antibody 
crosslinking occurs very fast and reaches the maximum in less than 3 min, whereas 
upon stimulation with beads the maximum was reached after 10-20 min. When NK 
cells get stimulated with target cells the kinetic resembles the one observed after 
antibody crosslinking (Endt et al, 2007). The antibody on the beads is immobile and 
cannot diffuse like in a target cell membrane or in solution. The NK cells wrap around 
the beads coated with specific antibody, as they cannot recruit the 'ligands' into a real 
synapse. This probably causes the slower onset of signaling after stimulation with 
beads. In target cells NKG2D ligands occur associated with lipid rafts in a clustered 
form, which is essential for effective activation of NK cells (Eleme et al, 2004). The 
preclustered ligands could facilitate and accelerate clustering of the receptors upon 
contact of the cells. The structure of an IS is much more complex than a receptor 
cluster initiated by receptor crosslinking or antibody coated beads. The response is 
not exclusively triggered by the stimulation of one activating or inhibitory receptor, but 
is induced by a composition of signals induced by various ligands on the target. We 
therefore confirmed that the signaling events we wanted to investigate after 
stimulation with antibody are not distinct from the effects caused by target cells.  
As our simulations are based on differential equations that describe the reactions, we 
needed to determine the concentration of molecules on the cell surface and in the 
cytoplasm. We first needed to compute the volumes of the relevant cellular 
compartments. Cells are no smooth spheres, but membrane ruffles can increase the 
real surface, compared to the volume. In order to simplify the calculation, we 
assumed a round cell shape. In our model we suppose a compartmentalization of the 
cytoplasm into the volume involved in synapse formation and the rest of the cell. 
During formation of the immunological synapse the cells can change their 
morphology leading to an increase in the size of the contact area (see Graham et al, 
2006; Vanherberghen et al, 2004 for representative images). We tried to take this 
into account and assumed a diameter of the IS compromising 55 % of the total cell 
diameter. The volume of the synapse compartment is composed of this area and only 
the membrane proximal 10 nm of the cytoplasm. The size of individual cells in the 
population can also differ from the mean values we used for the simulation and we 
observed donor dependent differences in primary NK cell populations. In NK cells 
and other lymphocytes the diameter of the whole cell is only a little bit larger than that 
of the nucleus. We considered this in our calculations but we did not take into 
account, that some of the proteins localize in or at the membrane, whereas other 
proteins are cytoplasmic. The volume of the cytoplasm is crowded with organelles 
and no homogeneous solution of molecules. The volume that is really accessible for 
a certain molecule might be much smaller than in our simulations. This would 
increase the relevant concentrations of the proteins, but on the other hand reduce the 
motility and the diffusion speed, as the proteins have to make long detours. 
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Quantification of surface molecules by FACS is quite exact and as it is a single cell 
analysis provides information about the distribution of the expression of a certain 
molecule in the population. The measurement of cytoplasmic proteins by western blot 
has higher experimental variability and averages all the cells per sample. Whereas all 
proteins quantified by FACS are located on the surface and should be in a functional 
state, western blot acquires all molecules present in the cell. By western blot it is not 
possible to distinguish between proteins in the relevant location and state and 
proteins that are already determined for degradation, currently trafficking or newly 
synthesized, therefore not 'functional'. Due to these uncertainties, the concentrations 
used for the simulations might not represent physiological relevant values. To 
reassure that this does not falsify our simulation result, our cooperation partner ran 
simulations with varied initial protein concentrations. Qualitatively, the simulation 
results were very robust against these changes. 
The results of this work are critically depending on the quantification of western blots. 
Therefore we were extremely cautious in controlling these results. Two major 
sources for errors in western blot results are irregularities of the gel and during 
protein transfer to the membrane. We minimized these problems by using precast 
gels that provide a higher homogeneity than self cast gels. Additionally we could 
show that the minigel system used does not produce errors correlated with the 
position of the sample on the gel, by randomized loading of the samples and/or 
internal control (Schilling et al, 2005). For quantification of protein phosphorylation we 
always used an appropriate loading control for the unphosphorylated protein or 
protein family. The signal of unphosphorylated controls was used to normalize the 
lanes of each blot. The specificity of the phospho-specific antibodies was reassured 
by using the phosphatase inhibitor pervanadate to induce maximal protein 
phosphorylation. The pSrc antibody used recognizes SFKs only if the activating 
tyrosine at position 416 is phosphorylated. Vav1 has three regulatory tyrosines in the 
acidic region. Phosphorylation of the two N-terminal regulatory tyrosines (Y142, 
Y160) facilitates the phosphorylation of Y174 and releases the protein from the 
autoinhibitory conformation. We used an antibody recognizing pY160, as activation of 
Vav1 goes along with phosphorylation of all three tyrosines. If it was necessary to 
use more than one blot per experiment due to bigger sample numbers, additional 
controls were used to normalize the distinct blots. The different methods to develop 
western blots can also influence the result. The linear range of ECL combined with X-
ray films to develop the blot is relatively small, but very sensitive. Acquisition of the 
ECL signal with a CCD camera provides a bigger linear range, but as we had no 
access to a suitable acquisition system this was not possible. Another possibility to 
develop western blots is by using (infrared) fluorescent secondary antibodies for 
detection. We tried to establish this method, but some of the primary antibodies, 
which could not be replaced by other products, did not work in this system. We 
therefore used X-ray films, but always scanned and quantified multiple exposures of 
every blot to reassure that the signal is not saturated. 
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When we used recombinant standard protein to quantify absolute protein 
concentrations these standards were initially controlled for purity and on a regular 
basis the concentration was monitored. The dilution of the standard was adjusted to 
produce a linear calibration curve in the concentration range of the cell lysates 
analyzed. Initial experiments showed, that loading of equal amounts of total protein 
per lane is crucial for homogeneous protein transfer to the blot membrane. 
Recombinant standard loaded pure in one lane could not be compared to the same 
amount of recombinant protein loaded together with cell lysate in one lane. All 
recombinant standard proteins used, differed in size from endogenous proteins and 
as neither the standard nor the endogenous protein produced unspecific signals they 
were always loaded combined in the same lane. This produced the best 
comparability of both signals. Different scanning and analysis methods have critical 
influence on the results (Gassmann et al, 2009), so we compared analysis of the 
same film with various methods. In our hands, using the mean optical density of the 
complete band provided the biggest linear range and the highest sensitivity 
compared e.g. to peak intensity or volume. 
5.3. Heterogeneous response of 'homogeneous' cell populations 
We observed in our microscopy experiments that the cells did not respond 
homogeneously to stimulation. After receptor crosslinking most cells relocalized the 
receptor and actin to one site of the cell starting within one minute after stimulation 
with maximum capping after 5-10 min. But some cells did not react to stimulation; the 
receptor remained homogeneously distributed around the cell, often showing a 
patchy staining. These patches probably represent small clusters of the receptor, 
either the receptor is already preclustered in unstimulated cells, or crosslinking with 
secondary antibody induces these clusters. The heterogeneous response could arise 
from differences in the cell cycle of the single cells (Rehm et al, 2009), as the 
cultures were not synchronized. Some cells are probably in a phase where they 
cannot respond to exogenous stimuli. These effects were not included in our model, 
as we simulated the response of a single cell that is completely responsive. Another 
reason for heterogeneous responses could be small differences in expression level 
of relevant molecules in single cells of the population. Previous work has 
demonstrated, that this variability within a population can have substantial influence 
on the reactivity towards stimulation (Feinerman et al, 2008). The Vav1 
phosphorylation determined experimentally by western blot averages the signal of 
many cells, whereas we simulate the response of a single cell. The experimentally 
observed pVav1 response is not as steep as in the simulation, especially in the 
concentration range where activating and inhibitory signals compete. Differences 
between single cells in the experimental sample could cause this 'blurry' response. 
From the experimental side, single cell analysis of signaling processes would be 
necessary to reveal how the reactions of the cells in a population are distributed 
around the average we measured, but unfortunately there are no suitable reagents 
available to date, to measure pVav1 e.g. by FACS. An approach to include this 
heterogeneity in the model and to simulate the behavior of cell populations is to use 
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stochastic equations that include effects arising from fluctuation around the average. 
Our cooperation partner chose to control the robustness of our model by variation of 
initial protein concentrations and analyzed the sensitivity of the response towards 
changes of multiple parameters at once. The qualitative response of our simulations 
was stable within a certain concentration range of involved proteins, but the 
amplitude of pVav1 was affected. These variations in the absolute phosphorylation 
levels of Vav1 in single cells could be responsible for the slight differences in the 
experimentally observed compared to the simulated dose-response. 
5.4. Signal transduction downstream of Vav1 
We focused in our simulations and the experiments on the events integrating the 
signals on the level of Vav1 phosphorylation. Downstream of pVav1 the signal is 
transmitted via various pathways. Our initial experiments with chemical inhibitors 
showed that Syk, PI3K, MEK, p38 and PLC do not influence the Vav1 
phosphorylation after stimulation of NKG2D. But PI3K, MEK, and PLC inhibition 
could completely block NKG2D dependent killing (data not shown). These results 
and previous work show, that these signaling steps are essential, but either 
downstream or parallel of Vav1 phosphorylation. In mice lacking Vav proteins it has 
been shown that the activation of ERK upon receptor stimulation is completely 
abrogated (Cella et al, 2004; Colucci et al, 2001). The MAPK pathway is usually 
activated via Rac-1, PAK signaling after phosphorylation of Vav proteins. We were 
able to detect double phosphorylated ERK after NKG2D stimulation, but using 
receptor crosslinking inter experimental variability was extremely high. We noted a 
high background phosphorylation, as the cells we used require IL-2 in the culture 
medium. This cytokine also induces ppERK but not other MAPK signals (Yu et al, 
2000) via pathways independent of Vav1. In IL-2 starved cells the background 
phosphorylation is lower or absent, but induction of ERK phosphorylation upon 
receptor triggering is hardly detectable. An additional experimental complication 
arises, as the ERK signal in our system reacts very sensitive to different kinds of 
stress e.g. changes of the temperature and centrifugation. When we used anti-
NKG2D coated beads, the induced ERK phosphorylation was very robust and 
showed a similar dose-response as pVav1. Probably the slower kinetic upon bead 
stimulation is beneficial for the specificity of the signal. As expected, relocalization of 
NKG2D and actin upon receptor crosslinking were not affected by MEK inhibition, 
excluding a negative feedback from the MAPK pathway to the actin rearrangement. 
The MAPK cascade offers possibilities for further amplification of the signal. It has 
been shown before, that the double phosphorylation of MAPK transforms incoming 
signals to show a steeper response or even a digital behavior (Altan-Bonnet and 
Germain, 2005; Huang and Ferrell, 1996). In our dose-response analysis the ppERK 
response shows a steeper increase than pVav1. So we assume, that this mechanism 
of signal amplification downstream of Vav1 also plays a role in the signaling cascade 
of NK cells.  
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The Ca2+ flux is initiated immediately upon activating receptor crosslinking and 
increases similar to the pVav1 kinetic until a plateau is reached. The peak level is in 
contrast to the Vav1 phosphorylation not transient, but stable for at least 20 min. The 
amplitude of the signal is associated with the stimulation strength, matching the 
pVav1 response. The dose-response of the Ca2+ signal is also very similar to the 
Vav1 phosphorylation, it increases rapidly upon activating receptor stimulation, but 
the signals of inhibitory receptors are dominant and can block the signal almost 
completely. Combined with the result, that blocking PLC-γ activity with a chemical 
inhibitor does not affect Vav1 phosphorylation, this suggest, that the Ca2+ signal is 
initiated downstream of pVav1. It has been proposed before, that PLC-γ recruitment 
to the membrane, and so the initiation of the Ca2+ signal, depends on pVav1 
(Graham et al, 2006). We propose that the Ca2+ flux is passing the signal integrated 
at the level of Vav1 on, to induce downstream effects, leading to an amplification and 
prolongation of the activation signal. 
Our hypothesis is that the activating and inhibitory signals are integrated at the level 
of Vav1, but how does this integration affect the cytotoxicity of the NK cells? The 
cytotoxic activity of NK cells shows the same dose-response as pVav1 upon 
differential triggering of activating and inhibitory receptors. The inhibitory signal is 
dominant over a large concentration range. Without inhibitory signal, low amounts of 
activating signal are sufficient to induce the maximal cytotoxicity. In a physiologic 
context, it is essential, that NK cells spare targets when they still express MHC 
class I to avoid autoimmune reactions damaging healthy tissues. But cells without 
inhibitory ligands are killed as soon as the NK cell receives activating stimulation, as 
loss of MHC class I is characteristic for many virus infections or transformation of the 
cell. The identical dose-response of cytotoxicity and pVav1 allows the conclusion that 
signals downstream of Vav1 are transmitted unaltered. Our data do not justify the 
converse argument, that there is no further signal integration, feedback loops or 
crosstalk between different pathways. In agreement with our hypothesis that Vav1 
integrates positive and negative signals, disturbances of the signal cascade by SFK 
inhibition show the same effect on the level of Vav1 as on the cytotoxic activity of NK 
cells. The alternative explanation, that the signals are integrated simultaneously in 
alternative pathways, would be very uneconomic and complicated, but we cannot 
exclude this possibility. As we disrupted the signal upstream of pVav1 this inhibition 
could also affect NK cell killing via other, pVav1 independent pathways, that depend 
also on the activity on SFKs. The real contribution of pVav1 for the cytotoxicity of 
human NK cells has to be further examined by disturbing the signals directly on the 
level of Vav1 e.g. by silencing Vav family members with siRNA or by pharmacological 
inhibition of the GEF activity of Vav proteins.  
5.5. Importance of Vav1 for the NK cell function 
The multiple domains of Vav1 provide many interaction possibilities. It can interact 
via the protein Grb2 with the NKG2D signaling adapter DAP10. Vav1 can bind via its 
PH domain to phosphoinositides, products of PI3K, which is also able to bind to 
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DAP10. Who's connected first with NKG2D after stimulation: PI3K or complexes of 
Grb2 and Vav1? It has been suggested that the interaction of Vav1 with DAP10 is 
necessary to recruit PI3K, as in the absence of Vav1 stimulation of NKG2D cannot 
induce Akt phosphorylation (Graham et al, 2006). But also the reverse model has 
been proposed, as it is assumed that phosphoinositides are recruiting proteins with 
PH domains to the membrane. Therefore it has been suggested, that the products of 
PI3K initiate Vav1 recruitment to the receptor. Binding assays in vitro could show an 
enhancement of GEF activity after phosphatidylinositol-3,4,5-trisphosphate and a 
reduction after phosphatidylinositol-4,5-bisphosphate binding to Vav1 (Han et al, 
1998; Jiang et al, 2000). It depends on the cell type and the signaling mechanisms of 
the receptor studied if Vav1 phosphorylation is independent of PI3K, or not. As in our 
system PI3K inhibition has no influence on Vav1 phosphorylation after NKG2D 
triggering we propose, that PI3K recruitment and activity is induced downstream of 
Vav1. We suggest that interaction of SFKs and Vav1 with the receptor initiate the 
pVav1 signal. The high local concentration of kinases in proximity to the receptor 
could allow phosphorylation of the regulatory tyrosines in the acidic region of Vav1. If 
these tyrosines are phosphorylated, Vav1 is released from its inactive autoinhibitory 
conformation. These phosphorylation events induce the GEF activity of Vav1 and 
enable the downstream signals. 
In lymphocytes, all three Vav family members are expressed, but if each of the 
proteins has specific functions or if the functions are redundant is not completely 
understood. NK cells develop normal in Vav1 deficient mice; they have regular NK 
cell numbers, with an unaltered pattern of surface receptors. In contrast, T cell 
development is blocked at the transition from double negative to double positive 
thymocytes. Also when all three Vav family members are missing, NK cell 
development is not abrogated (Cella et al, 2004; Colucci et al, 2001). Studies with 
Vav1 knock out mice showed that Vav1 is important for in vivo tumor clearance. 
Further investigation revealed a severe defect in cytotoxicity mediated by various 
receptors including FcRγ, 2B4 and NKG2D. The IFNγ production was unaffected in 
these mice. In a different study the effects of all three Vav family members 
downstream of various receptors were investigated to elucidate possible 
redundancies of Vav proteins in NK cells. The signaling of NKG2D/DAP10 was 
largely Vav1 dependent, but in contrast to the previous study the signals of FcRγ and 
DAP12 were identified to be mainly mediated by Vav2 and 3. In mice the redundancy 
between Vav1 and the other two family members seem to depend on the cell type 
and the function examined. Whereas Vav1 seems to be essential in T cells for 
proliferation and the induction of a normal Ca2+ response upon TCR engagement, B 
cells are only affected after deletion of at least two of the three Vav proteins 
(Fujikawa et al, 2003). The studies examining redundancy of the Vav family members 
have been done in mice, further studies have to answer the question if Vav proteins 
are able to compensate the functions of each other in human NK cells. In our system 
stimulation of receptors transmitting the signals via DAP10, ITSM motifs and ITAM 
motifs induce pVav1, but we did not test the involvement of other Vav family 
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members. As the amino acid sequence of the acidic region of the Vav proteins is 
quite different the pVav1 antibody should not cross-react with Vav2 and 3, but we did 
not have the possibility to test this experimentally. For Vav2 and 3 the direct 
interaction with SHP-1 has not been shown, therefore the question arises if signals 
mediated by these proteins are inhibited with the same or a similar mechanism. 
The studies on Vav deficient mice suggest, that the different effector functions of NK 
cells do not rely on the same signaling pathways. The cytokine production is not 
affected by the lack of Vav proteins in the same way as the cytotoxicity downstream 
of the same receptor. After stimulation of one specific receptor the signal is 
transmitted via Vav dependent and independent pathways, initiating different effector 
functions. But whereas the cytokine production can be unaffected under identical 
conditions, Vav proteins are indispensable for cytotoxicity upon engagement of 
various NK cell receptors. 
Recently it has been shown, that also induced phosphorylation of the adapter protein 
CrkII contributes to the inhibition mediated by ITIM carrying receptors (Peterson and 
Long, 2008). Under activating conditions the scaffolding protein c-Cbl interacts with 
the SH2 domain of Vav1. Complexes of CrkII with c-Cbl and the GEF C3G are also 
detectable. Actin rearrangement and lamellipodia formation are promoted by the 
interaction of CrkII with c-Cbl. ITIM signals promote phosphorylation of CrkII, 
probably via the kinase c-Abl, leading to disruption of the complexes necessary for 
NK cell activation. If these events occur in parallel or downstream of the signaling 
events analyzed by us has to be investigated, because it is not clear if Vav1 is 
necessary to transmit the signals from ITIMs to CrkII. 
5.6. Robust, predictive simulations of NK cell activation 
Our model including the association of the kinase with the receptor offers the 
possibility to make realistic end point simulations of the pVav1 response of NK cells 
towards activating and inhibitory signals. We tested our model further because we 
wanted to know if the model is also able to produce realistic time course simulations. 
The predictions from the model that the kinetic of Vav1 phosphorylation would not 
change when the activating (or inhibitory, data not shown) stimulus is varied could be 
confirmed experimentally. Almost identically, the maximum phosphorylation is 
reached within 3 min after stimulation, indicating that the kinetic parameters used for 
our simulation are in a physiological relevant range. In our model, the level of pVav1 
stays constant, once a plateau is reached, but in the experiment we observed a 
decrease in Vav1 phosphorylation between 5 and 10 min after stimulation. This 
indicates, that there exists at least one mechanism, probably a negative feedback 
loop, to shut off the activating signal although the initiating signal is still present. A 
possible mechanism to shut down signaling processes is the internalization and 
turnover of the respective receptor after stimulation (Alvarez-Arias and Campbell, 
2007; Sandusky et al, 2006). Engagement of other receptors leads to a dramatic 
reduction of their surface expression through shedding from the surface (Grzywacz et 
al, 2007), showing that NK cell activation can be modulated on the receptor level. It 
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has been shown for some ligands, that they are transferred rapidly after conjugation 
with the target cell to the NK cell, but how these ligands are involved in modulating 
the NK cell activity has to be investigated (McCann et al, 2007). Another possible 
reason, why the pVav1 level gets reduced is, that as soon as the downstream 
effectors are also recruited, they displace Vav1 from the synapse. We did not include 
any mechanism in our model that could terminate the signal therefore the pVav1 
level stays constant once the plateau is reached. The slope of the onset of Vav1 
phosphorylation and the maximum levels can be simulated in a realistic way.  
The kinetic parameters used in the model have been excessively tested by our 
cooperation partner, using two completely different ways of analysis. The parameter 
scan as well as the parameter fit could show, that the simulation results are very 
stable in producing a physiological response provided that kinase association is 
included. Models lacking this module could not be forced by parameter changes to 
produce this response. This reassured us, that the results of our simulations are 
specific for the reactions we included, as the model is not sensitive to parameter 
changes. By manipulating the parameters we could never cause the same impact, as 
by addition of the kinase association module (c). Therefore we are confident, that we 
could identify key concepts of the signal integration of NK cells.  
It is intriguing to transfer this model to other immune cells that also receive activating 
and inhibitory stimulation, e.g. a subset of CD4+/CD8+ and γδ T cells also express 
KIRs. T cells can acquire stable expression of KIRs after completion of their 
rearrangement of the TCR locus, and the number of KIR positive T cells increases 
with the age (Ugolini and Vivier, 2000). Co-ligation of the TCR and KIRs can down 
modulate or completely inhibit cytokine production and cytotoxicity of CD8+ T cells 
(Phillips et al, 1995). The mechanism inducing the expression and the functional 
consequences are not fully understood. KIRs are mainly expressed on cells with a 
memory like phenotype, probably because they protect the cell from activation 
induced cell death. Maybe it is also a mechanism to maintain tolerance and prevent 
autoimmunity, e.g. in chronic infections. The signaling properties of the KIR receptors 
seem to be critically depending on the activation status of the cell. Investigating these 
connections by mathematical modeling could help to reveal the mechanisms causing 
the effects of KIR triggering on T cells.  
Manipulation of the model system offers - compared to manipulations of cells - a 
quick and easy possibility to test the effects of perturbations on NK cell activity. We 
successfully predicted the effects of SFK inhibition with our model. Changing the 
stimulus strength did not affect the kinetic of Vav1 phosphorylation, but reducing the 
activity of the kinase predicted a slower increase and retarded maximum. By 
inhibition of SFKs we experimentally confirmed this slower kinetic. The maximum of 
Vav1 phosphorylation was also decreased in the simulation and in our experiment. 
SFK inhibition had exactly the same impact on Vav1 phosphorylation as on 
cytotoxicity: the amplitude was reduced, but the dose-response was not affected. 
Using the chemical inhibitors it is impossible to control, if we reduced the activity to 
the same extent as in the simulation, but this result has strong qualitative 
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significance. Models like this could be extremely helpful in identifying effective targets 
to modulate NK cell activity. For the treatment of various diseases therapeutic 
approaches try to utilize the power of NK cells. Most of these approaches aim at 
enhancing the expression of activating ligands on tumor or infected cells or to reduce 
interactions of inhibitory NK cell receptors with their ligands (Romagne et al, 2009; 
Vales-Gomez et al, 2008). To harness the cytotoxic potential of NK cells, it could be 
of advantage to identify effective disturbances by simulations first and then 
evaluating the effect experimentally. For example, our model would predict, that if we 
wanted to overcome the dominance of inhibitory signals it would have a small effect 
to target the interactions of inhibitory receptors and their ligands. Interfering with the 
activity of phosphatases also would not be very efficient. But a substance disrupting 
the interaction of inhibitory receptors and phosphatases would potently enhance NK 
cell activity against MHC class I low targets. Mathematical modeling is a powerful 
method to help us to understand complex signaling processes and to reveal key 
regulatory mechanisms. The insight gained about the signal integration can be used 
to identify new effective therapeutic strategies.  
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7. Abbreviations 
ADCC antibody-dependent cellular cytotoxicity 
CD  cluster of differentiation 
CRACC  CD2-like receptor-activating cytotoxic cells 
CTX  Choleratoxin  
DAP  DNAX activation protein 
DC  dendritic cells 
DMSO  Dimethylsulfoxide 
E.coli  Escherichia coli 
ERK  Extracellular signal-regulated kinase 
GEF  guanine exchange factor 
GM-CSF  granulocyte-macrophage colony-stimulating factor 
GST  glutathione-S-transferase 
GTPases  guanosine triphosphatase 
HLA  human leukocyte antigen 
IFN  interferon 
Ig  Immunoglobulin  
IL  interleukin 
IS  immunological synapse  
ITAM  immunoreceptor tyrosine-based activation motif 
ITIM  immunoreceptor tyrosine-based inhibition motif  
ITSM  immunoreceptor tyrosine-based switch motif 
KIR  killer cell Ig-like receptors  
Klra  killer cell lectin-like receptor family a 
LFA  lymphocyte function-associated antigen 
LILR  leukocyte immunoglobulin like receptor 
MAPK  mitogen activated protein kinase 
MEK  mitogen-activated protein kinase kinase 
MFI  mean fluorescence intensity 
MHC  major histocompatibility complex  
MICA/B  MHC class I related chain A and B  
min minute 
MTOC microtubule-organizing center 
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NCR  natural cytotoxicity receptors  
NK  Natural killer  
PBL  peripheral blood lymphocytes  
PI3K  phosphatidylinositol-3-kinase 
PLC  phospholipase C  
SDS-PAGE  sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SFK  Src family kinases 
SHP  SH2 containing protein tyrosine phosphatases 
Siglecs  sialic-acid-binding immunoglobulin-like lectins 
SLAM signaling lymphocyte activation molecule 
SRR  SLAM related receptors 
TNF  tumor necrosis factor 
 
